ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
5,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
5,2,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
6,1,Urticarial vasculitis,Urticarias,Angioedema and urticaria,Skin,N
7,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
8,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
9,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
9,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
9,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
9,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
11,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
11,3,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
11,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
11,5,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
12,1,Urticarial vasculitis,Urticarias,Angioedema and urticaria,Skin,N
13,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
13,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
13,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
14,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
15,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
16,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
16,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
17,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
18,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
19,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
20,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
20,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
21,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
22,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
22,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
23,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
23,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
24,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
25,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
26,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
27,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
28,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
29,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
29,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
30,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
31,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
31,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
31,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
31,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
32,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
33,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
34,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
35,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
36,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
37,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
37,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
38,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
38,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
38,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
38,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Coronary angioplasty,Arterial therapeutic procedures (excl aortic),Vascular therapeutic procedures,Surg,N
39,2,Vascular stent occlusion,Vascular complications associated with device,Complications associated with device,Genrl,N
40,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
40,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
40,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
42,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
42,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
43,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
44,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
45,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
46,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
46,2,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
46,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
46,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
46,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
47,1,Pemphigus,Bullous conditions,Epidermal and dermal conditions,Skin,Y
48,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
48,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
49,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
49,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
49,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
50,1,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
51,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
52,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
52,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
52,3,Pemphigus,Bullous conditions,Epidermal and dermal conditions,Skin,N
53,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
53,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
54,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
55,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
55,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
55,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
55,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
55,5,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
56,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
56,2,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
57,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
57,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
57,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
57,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
57,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
57,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
57,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
58,1,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
59,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
59,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
60,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
60,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
60,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
60,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
61,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
61,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
61,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
61,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
62,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
62,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
63,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
63,2,Headache,Headaches NEC,Headaches,Nerv,N
63,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
63,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
65,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
65,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
66,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
67,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
68,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
69,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
69,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
70,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
70,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
70,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,Y
70,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
71,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
72,1,Spleen disorder,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
73,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
74,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
74,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
74,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
75,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
75,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
75,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
75,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
76,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
77,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
77,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
77,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
78,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
79,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
80,1,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,Y
81,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
82,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
83,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
84,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
85,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
85,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
86,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
87,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
87,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
87,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
87,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
87,5,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
87,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
88,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
88,2,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
89,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
89,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
89,3,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
90,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,Y
91,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
91,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
92,1,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
93,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
94,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
95,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
95,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
95,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
95,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
95,5,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
95,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
96,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
96,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
96,3,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
96,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
97,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
98,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
98,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
98,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
98,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
99,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
100,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
101,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
102,1,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
102,2,Endocarditis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
102,3,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
102,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
102,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
103,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
104,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
105,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
106,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
107,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
107,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
108,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
108,2,Troponin T increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
109,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
110,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
111,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
112,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
112,2,Gastrointestinal oedema,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
112,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
113,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
113,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
113,3,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
114,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
115,1,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
115,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
116,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
117,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
118,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
119,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
119,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
119,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
119,4,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
120,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
120,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
121,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
121,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
122,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
123,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
124,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
125,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
126,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
127,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
128,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
129,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
130,1,Oropharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
130,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
131,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
132,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
133,1,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
134,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
135,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
135,2,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
135,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
136,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
137,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
137,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
137,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
138,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
139,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
139,2,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
139,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
139,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
140,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
141,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
142,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
142,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
142,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
143,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
144,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
144,2,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
144,3,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
145,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
145,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
145,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
145,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
145,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
145,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
146,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
146,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
146,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
147,1,Splenic rupture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,Y
148,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
149,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
150,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
151,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
152,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
153,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
154,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
155,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
156,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
156,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
157,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
158,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
159,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
159,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
159,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
160,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
160,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
160,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
161,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
161,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
161,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
161,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
162,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
163,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
163,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
163,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
163,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
164,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
165,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
165,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
166,1,Meningitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
167,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
168,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
169,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
169,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
170,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
170,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
171,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
171,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
172,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
172,2,Ovarian cancer metastatic,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
172,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
173,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
173,2,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
174,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,Y
175,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
175,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
175,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
176,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
176,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
176,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
176,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
176,5,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
177,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
177,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
178,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
179,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
179,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
180,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
180,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
180,3,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
180,4,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
180,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
180,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
180,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
181,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
181,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
182,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
182,2,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
183,1,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,Y
184,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
184,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
184,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
184,4,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
184,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
184,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
184,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
185,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
185,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
186,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
187,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
188,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
189,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
190,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,Y
190,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
190,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
191,1,Carditis,Cardiac infections and inflammations NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
192,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
193,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
194,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
195,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
195,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
196,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
196,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
196,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
196,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
197,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
197,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
197,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
197,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
197,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
197,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
198,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
199,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
199,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
199,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
199,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
199,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
199,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
199,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
199,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
200,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
201,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
201,2,Meningitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,Y
201,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
201,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
202,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
203,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
204,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
205,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
205,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
205,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
205,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
205,5,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
206,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
207,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
207,2,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
208,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
209,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
210,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
210,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
210,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
211,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
211,2,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
212,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
213,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
214,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
215,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
216,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
216,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
217,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
217,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
218,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
218,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
219,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
219,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
220,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
221,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
221,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
222,1,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
223,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
224,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
225,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
225,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
226,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
227,1,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
228,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
228,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
228,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
229,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
229,2,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
229,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
230,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
230,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
230,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
230,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
231,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
232,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
233,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
233,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
233,3,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
233,4,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
233,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
234,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
234,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
234,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
235,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
236,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
237,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
237,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
237,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
237,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
237,5,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
237,6,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
237,7,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
237,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
238,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
238,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
238,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
239,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
240,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
240,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
240,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
240,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
241,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
242,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
243,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
244,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
245,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
245,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
246,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
247,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
248,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
248,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
249,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
250,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
250,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
250,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
251,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
251,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
251,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
251,4,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
252,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
252,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
252,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
253,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
254,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,Y
255,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
256,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
256,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
257,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
258,1,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
258,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
259,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
260,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
260,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
260,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
261,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
262,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
262,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
262,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
262,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
262,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
263,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
264,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
265,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
266,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
267,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
268,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
269,1,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
270,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
271,1,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
271,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
271,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
271,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
272,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
273,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
273,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
273,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
274,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
274,2,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,N
275,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
276,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
277,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
277,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
278,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
279,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,Y
280,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
281,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
281,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
281,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
281,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
282,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
282,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
282,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
283,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
284,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
285,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
286,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
286,2,Headache,Headaches NEC,Headaches,Nerv,N
286,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
287,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
288,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
289,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
290,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
291,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
291,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
292,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
292,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
292,3,Vaginal fistula,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
293,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
294,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
295,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
295,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
296,1,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
297,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
298,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
299,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
300,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
301,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
302,1,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,Y
303,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
303,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
304,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
305,1,Inflammatory carcinoma of the breast,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
306,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
307,1,Cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
308,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
308,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
308,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
309,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
310,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
310,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
310,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
310,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
310,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
310,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
310,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
311,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
312,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
313,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
313,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
313,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
313,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
314,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
315,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
316,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
317,1,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
317,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
317,3,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
317,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
318,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
319,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
320,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
321,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
321,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
322,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
322,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
323,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
324,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
324,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
324,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
324,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
324,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
325,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
326,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
326,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
326,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
327,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
328,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
328,2,Headache,Headaches NEC,Headaches,Nerv,N
328,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
328,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
329,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
330,1,Headache,Headaches NEC,Headaches,Nerv,N
330,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
330,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
330,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
331,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
332,1,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
332,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
333,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
334,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
334,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
334,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
334,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
335,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
336,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
336,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
336,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
336,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
336,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
336,6,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
336,7,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
336,8,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
336,9,Nodular regenerative hyperplasia,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
336,10,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
336,11,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
336,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
336,13,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
336,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
336,15,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
336,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
337,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
337,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
337,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
338,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
339,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
339,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
339,3,Headache,Headaches NEC,Headaches,Nerv,N
339,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
339,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
339,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
339,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
339,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
339,9,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
339,10,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
339,11,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
340,1,Headache,Headaches NEC,Headaches,Nerv,N
340,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
340,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
340,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
341,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
341,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
341,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
341,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
341,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
342,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
342,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
342,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
342,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
343,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
343,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
343,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
343,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
343,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
343,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
343,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
344,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
345,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
346,1,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
346,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
346,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
346,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
346,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
347,1,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
347,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
347,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
347,4,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
347,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
347,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
347,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
348,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
349,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
349,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
350,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
351,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
352,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
353,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
354,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
355,1,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
356,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
357,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
358,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
359,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
360,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
361,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
362,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
363,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
364,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
364,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
364,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
364,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
365,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
365,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
365,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
365,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
365,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
365,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
365,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
365,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
365,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
365,10,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
365,11,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
366,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
367,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
368,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
368,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
368,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
368,4,CD19 lymphocytes decreased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
368,5,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
368,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
368,7,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
368,8,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
368,9,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
368,10,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
368,11,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
368,12,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
368,13,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
368,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
368,15,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
368,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
369,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
369,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
369,3,Serum sickness-like reaction,Allergic conditions NEC,Allergic conditions,Immun,N
369,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
370,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
370,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
370,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
370,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
370,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
371,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
371,2,Headache,Headaches NEC,Headaches,Nerv,N
371,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
372,1,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
372,2,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
373,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
373,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
373,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
373,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
374,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
374,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
374,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
375,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
376,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
376,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
377,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
377,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
377,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
377,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
377,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
377,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
377,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
377,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
377,10,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
377,11,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
377,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
378,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
378,2,Headache,Headaches NEC,Headaches,Nerv,N
378,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
379,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
379,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
379,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
379,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
379,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
379,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
380,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
380,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
380,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
380,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
380,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
380,6,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
380,7,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
381,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
381,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
381,3,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
382,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
383,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
383,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
383,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
383,4,CD19 lymphocytes decreased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
383,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
383,6,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
383,7,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
383,8,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
383,9,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
383,10,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
383,11,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
383,12,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
384,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
385,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
385,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
385,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
385,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
385,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
386,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
386,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
387,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
388,1,Connective tissue disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
389,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
390,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
391,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
392,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
393,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
394,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
394,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
394,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
394,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
394,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
395,1,Acute myelomonocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
396,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
397,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
398,1,Renal necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
399,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
400,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
400,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
400,3,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
401,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
402,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
402,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
402,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
403,1,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
404,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
404,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
405,1,Bacterial test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
406,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
406,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
406,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
407,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
407,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
407,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
408,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
408,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
408,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
408,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
409,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
409,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
410,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
410,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
411,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
411,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
412,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
412,2,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
412,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
412,4,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
412,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
413,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
413,2,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,Y
413,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
413,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
414,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
415,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
415,2,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
415,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
416,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
416,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
416,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
417,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
417,2,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
417,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
417,4,Encephalitis cytomegalovirus,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
417,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
417,6,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
417,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
417,8,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
417,9,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
418,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
418,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
418,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
418,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
418,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
418,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
418,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
418,8,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
418,9,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
418,10,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,Y
418,11,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
418,12,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
419,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
420,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
420,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
421,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
421,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
421,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
421,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
421,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
421,6,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
421,7,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
421,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
421,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
422,1,Porocarcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
423,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
423,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
423,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
423,4,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,Y
423,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
423,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
423,7,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
424,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
425,1,Headache,Headaches NEC,Headaches,Nerv,N
425,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
425,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
425,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
426,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
426,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
427,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
427,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
427,3,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
427,4,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
427,5,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
427,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
428,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
428,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
429,1,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
430,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
431,1,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
432,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
433,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
434,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
434,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
434,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
435,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
435,2,Cerebral ventricle dilatation,Structural brain disorders NEC,Structural brain disorders,Nerv,N
435,3,Thrombocytopenia neonatal,Thrombocytopenias,Platelet disorders,Blood,N
436,1,Toxic cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
437,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
437,2,Non-cardiogenic pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
437,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
438,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
439,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
439,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
440,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
440,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
441,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
442,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
443,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
444,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
445,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
445,2,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
446,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
447,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
448,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
449,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
449,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
449,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
449,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
449,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
450,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
451,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
451,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
452,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
453,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
454,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
455,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
455,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
455,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
456,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
456,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
456,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
457,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
458,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
459,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
460,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
461,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
461,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
462,1,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
462,2,Bursitis infective staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
462,3,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
462,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
462,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
463,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
463,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
463,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
463,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
463,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
464,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
464,2,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
465,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
465,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
466,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
466,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
467,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
468,1,Meningism,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
469,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
470,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
471,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
472,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
472,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
472,3,Migraine,Migraine headaches,Headaches,Nerv,N
472,4,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
472,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
473,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
473,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
473,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
474,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
475,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
476,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
477,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
477,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
478,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
479,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
480,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
480,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
481,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
481,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
482,1,Convulsive threshold lowered,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
482,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
483,1,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
483,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
484,1,Breast cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
485,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
486,1,Encephalitis herpes,Herpes viral infections,Viral infectious disorders,Infec,N
487,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
488,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
488,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
488,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
489,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
489,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
490,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
491,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
491,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
491,3,Supraventricular tachyarrhythmia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
492,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
493,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
493,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
494,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
495,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
495,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
495,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
496,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
497,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
498,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
499,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
499,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
500,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
500,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
501,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
502,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
502,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
502,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
503,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
503,2,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
503,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
504,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
505,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
505,2,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
505,3,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
505,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
505,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
505,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
505,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
506,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
506,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
506,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
506,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
506,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
507,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
508,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
509,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
509,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
509,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
509,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
509,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
509,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
509,7,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
510,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
510,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
510,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
511,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
512,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
513,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
513,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
513,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
514,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
514,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
514,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
514,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
514,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
515,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
516,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
516,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
516,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
517,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
518,1,Gingival abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
519,1,B-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
519,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
519,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
520,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
521,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
521,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
522,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
523,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
523,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
523,3,Device related bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
523,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
523,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
523,6,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
523,7,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
523,8,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
523,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
523,10,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
523,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
523,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
523,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
523,14,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
523,15,Tic,Tic disorders,Changes in physical activity,Psych,N
524,1,Bladder fibrosis,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
524,2,Catheterisation venous,Venous therapeutic procedures,Vascular therapeutic procedures,Surg,N
524,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
524,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
524,5,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
524,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
524,7,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
525,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
526,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
526,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
526,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
527,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
528,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
528,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
529,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
530,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
531,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
532,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
532,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
532,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
532,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
532,5,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
533,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
534,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
535,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
536,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
536,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
536,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
536,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
536,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
537,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
537,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
538,1,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
538,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
538,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
538,4,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
539,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
539,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
540,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
541,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
541,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
541,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
541,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
542,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
543,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
544,1,Central nervous system viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
545,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
545,2,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
545,3,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
546,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
546,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
546,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
546,4,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
546,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
547,1,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
547,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
548,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
549,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
549,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
549,3,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
549,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
550,1,Renal necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
551,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
551,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
551,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
551,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
551,5,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
551,6,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
551,7,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
551,8,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
551,9,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
551,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
551,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
552,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
553,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
554,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
554,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
554,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
554,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
554,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
554,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
554,7,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
554,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
555,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
556,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
557,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
558,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
559,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
559,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
559,3,Bedridden,Disability issues,Lifestyle issues,SocCi,N
559,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
559,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
559,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
560,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
561,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
561,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
562,1,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
562,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
563,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
563,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
563,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
563,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
564,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
565,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
566,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
566,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
566,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
566,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
566,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
567,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
567,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
568,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
568,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
568,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
568,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
569,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
570,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
571,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
571,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
572,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
573,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
573,2,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
574,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
574,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
574,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
574,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
575,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
575,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
576,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
576,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
576,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
576,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
576,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
576,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
576,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
576,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
576,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
577,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
577,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
577,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
578,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
578,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
578,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
578,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
579,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
579,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
579,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
580,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
581,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
582,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
583,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
583,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
583,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
583,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
583,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
583,6,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
583,7,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
583,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
584,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
585,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
585,2,Headache,Headaches NEC,Headaches,Nerv,N
585,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
585,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
586,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
586,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
587,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
588,1,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
589,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
589,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
589,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
589,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
590,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
590,2,Staphylococcal skin infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
591,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
591,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
591,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
591,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
592,1,Megakaryocytes abnormal,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
592,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
593,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
594,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
594,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
595,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
595,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
596,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
596,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
596,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
596,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
596,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
596,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
597,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
597,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
598,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
598,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
598,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
599,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
599,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
599,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
600,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
601,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
602,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
602,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
602,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
603,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
603,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
604,1,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
605,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
606,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
606,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
607,1,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
608,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
609,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
609,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
609,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
610,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
610,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
610,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
610,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
611,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
612,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
613,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
613,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
614,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
614,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
614,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
614,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
615,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
616,1,Ear infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
616,2,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
616,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
616,4,Immunodeficiency common variable,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
616,5,Immunoglobulin therapy,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
616,6,Lower respiratory tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
616,7,Sinusitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
617,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
618,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
618,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
619,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
619,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
619,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
620,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
620,2,Headache,Headaches NEC,Headaches,Nerv,N
620,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
620,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
621,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
622,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
622,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
622,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
623,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
623,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
624,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
625,1,Cerebral fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
626,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
627,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
627,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
628,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
628,2,Serum sickness-like reaction,Allergic conditions NEC,Allergic conditions,Immun,N
629,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
629,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
629,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
630,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
630,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
630,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
630,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
630,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
631,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
631,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
632,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
632,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
633,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
633,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
633,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
634,1,Cerebral fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
635,1,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
636,1,JC polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
636,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
637,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
638,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
638,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
639,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
640,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
641,1,Blood immunoglobulin A decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
641,2,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
641,3,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
641,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
642,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
642,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
643,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
644,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
644,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
645,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
646,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
647,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
648,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
649,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
650,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
651,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
652,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
653,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
654,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
654,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
655,1,Renal amyloidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,Y
656,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
656,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
657,1,Anogenital warts,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
657,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
657,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
657,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
658,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
658,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
658,3,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
658,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
659,1,B-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
660,1,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
661,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
662,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
662,2,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
662,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
662,4,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
663,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
663,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
664,1,Headache,Headaches NEC,Headaches,Nerv,N
664,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
665,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
666,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
667,1,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
668,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
668,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
669,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
669,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
670,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
670,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
670,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
670,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
671,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
671,2,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
671,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
671,4,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
672,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
672,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
672,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
672,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
672,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
673,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
673,2,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
674,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
674,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
675,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
675,2,Headache,Headaches NEC,Headaches,Nerv,N
675,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
675,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
675,5,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
675,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
676,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
676,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
677,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
677,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
678,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
679,1,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
679,2,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,Y
679,3,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
679,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
679,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
679,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
680,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
680,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
680,3,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
680,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
680,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
680,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
680,7,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
680,8,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
680,9,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
680,10,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
680,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
680,12,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
680,13,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
680,14,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
680,15,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
680,16,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
680,17,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
681,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
681,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
681,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
681,4,Sensation of blood flow,Feelings and sensations NEC,General system disorders NEC,Genrl,N
682,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
683,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
683,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
683,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
683,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
684,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
684,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
685,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
685,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
685,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
686,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
687,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
687,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
687,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
687,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
688,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
689,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
689,2,Headache,Headaches NEC,Headaches,Nerv,N
689,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
689,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
689,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
689,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
689,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
690,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
691,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
691,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
692,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
692,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
693,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
693,2,Epstein-Barr virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
693,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
693,4,Intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
693,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
693,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
694,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
695,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
695,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
695,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
696,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
696,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
697,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
697,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
698,1,Breast discharge,Breast signs and symptoms,Breast disorders,Repro,N
698,2,Invasive papillary breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
699,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
700,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
701,1,Headache,Headaches NEC,Headaches,Nerv,N
701,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
701,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
701,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
701,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
702,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
702,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
702,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
703,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
703,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
703,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
703,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
704,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
705,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
706,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
707,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
708,1,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
709,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
709,2,Headache,Headaches NEC,Headaches,Nerv,N
710,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
710,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
711,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
711,2,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
711,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
711,4,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,Y
711,5,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
711,6,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
711,7,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
711,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
711,9,Paraspinal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
711,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
711,11,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
711,12,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
712,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
713,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
713,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
714,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
715,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
716,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
717,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
717,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
718,1,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
718,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
719,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
720,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
721,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
721,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
721,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
721,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
722,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
722,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
722,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
723,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
724,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
724,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
725,1,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
725,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
726,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
727,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
728,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
728,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
728,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
728,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
728,5,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
728,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
729,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
729,2,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
729,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
730,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
730,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
731,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
731,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
731,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
732,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
732,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
733,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
734,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
735,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
735,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
735,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
736,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
736,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
736,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
736,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
736,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
736,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
737,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
737,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
738,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
738,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
739,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
740,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
741,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
742,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
742,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
743,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
744,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
744,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
744,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
744,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
745,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
745,2,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
745,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
745,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
746,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
746,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
746,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
746,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
746,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
746,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
746,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
746,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
746,9,Type III immune complex mediated reaction,Allergic conditions NEC,Allergic conditions,Immun,N
746,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
747,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
748,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
748,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
749,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
749,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
749,3,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
749,4,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
749,5,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
749,6,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
749,7,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
749,8,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
749,9,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
749,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
749,11,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
750,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
751,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
751,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
751,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
752,1,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
753,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
753,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
754,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
754,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
754,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
754,4,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
754,5,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
755,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
755,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
756,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,Y
757,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
757,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
757,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
758,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
758,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
759,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
759,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
760,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
760,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
760,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
761,1,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
762,1,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
763,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
763,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
763,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
764,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
765,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
766,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
766,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
766,3,Headache,Headaches NEC,Headaches,Nerv,N
766,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
767,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
768,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
768,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
768,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
768,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
768,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
768,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
768,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
768,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
769,1,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
770,1,Breast neoplasm,Breast neoplasms unspecified malignancy,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
771,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
771,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
771,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
771,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
771,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
771,6,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
772,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
773,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
774,1,Headache,Headaches NEC,Headaches,Nerv,N
774,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
774,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
774,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
775,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
775,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
776,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
776,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
776,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
776,4,Headache,Headaches NEC,Headaches,Nerv,N
776,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
776,6,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
776,7,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
776,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
777,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
778,1,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
779,1,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
780,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
781,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
781,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
781,3,Headache,Headaches NEC,Headaches,Nerv,N
781,4,Procedural nausea,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
782,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
782,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
782,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
783,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
783,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
784,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
784,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
784,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
785,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
786,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
787,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
788,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
788,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
788,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
788,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
788,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
789,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
789,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
789,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
789,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
789,5,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
790,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
791,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
792,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
792,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
793,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
794,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
794,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
794,3,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
794,4,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
794,5,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
794,6,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
794,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
794,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
794,9,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
794,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
794,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
794,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
794,13,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
794,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
795,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
795,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
796,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
796,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
797,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
797,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
798,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
798,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
798,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
798,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
799,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
800,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
801,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
801,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
802,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
803,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
804,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
804,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
804,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
804,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
805,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
806,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
807,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
808,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
808,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
808,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
808,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
809,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
810,1,Graft infection,Infections NEC,Infections - pathogen unspecified,Infec,N
811,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
812,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
812,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
813,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
814,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
815,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
816,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
817,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
818,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
819,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
820,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
821,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
821,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
822,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
822,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
822,3,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
823,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
823,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
824,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
825,1,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
826,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
826,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
826,3,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
827,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
828,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
828,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
828,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
828,4,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
828,5,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
828,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
828,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
828,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
828,9,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
828,10,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
828,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
828,12,Pleural thickening,Pleural conditions NEC,Pleural disorders,Resp,N
828,13,Pulmonary vasculitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
828,14,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
828,15,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
828,16,Spirometry abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
828,17,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
828,18,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
829,1,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
829,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
830,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
830,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
830,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
831,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
832,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
833,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
834,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
835,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
836,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
836,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
836,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
837,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
837,2,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
837,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
838,1,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
839,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
839,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
839,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
839,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
839,5,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
839,6,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
839,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
839,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
839,9,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
839,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
839,11,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
839,12,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
839,13,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
839,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
840,1,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
841,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
841,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
841,3,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
841,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
841,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
841,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
842,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
843,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
843,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
843,3,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
843,4,Metastases to adrenals,Metastases to specified sites,Metastases,Neopl,N
844,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
845,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
845,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
846,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
846,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
847,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
847,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
848,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
848,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
848,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
849,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
849,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
849,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
849,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
850,1,Ovarian cancer metastatic,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
851,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
852,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
852,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
852,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
853,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
854,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
855,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
856,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
856,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
857,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
857,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
857,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
858,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
858,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
858,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
859,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
860,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
860,2,Headache,Headaches NEC,Headaches,Nerv,N
860,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
860,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
861,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
861,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
862,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
862,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
863,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
863,2,Bronchostenosis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
863,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
863,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
863,5,Nasal septum disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
863,6,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
863,7,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
864,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
865,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
865,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
865,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
865,4,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
865,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
865,6,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
865,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
866,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
866,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
867,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
867,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
867,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
867,4,Gaze palsy,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
867,5,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
868,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
868,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
868,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
868,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
868,5,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
869,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
869,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
870,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
870,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
870,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
870,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
870,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
870,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
870,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
870,8,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
870,9,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
871,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
871,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
871,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
871,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
871,5,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
871,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
871,7,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
871,8,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
871,9,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
871,10,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
871,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
871,12,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
871,13,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
871,14,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
871,15,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
872,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
872,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
873,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
874,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
875,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
876,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
877,1,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
878,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
879,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
879,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
879,3,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
879,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
880,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
881,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
881,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
881,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
881,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
881,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
882,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
882,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
882,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
882,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
882,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
882,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
883,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
884,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
885,1,Cytokine storm,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
886,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
886,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
887,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
887,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,Y
888,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
889,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
889,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
889,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
889,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
889,5,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
889,6,Colonic fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
889,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
889,8,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
889,9,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
889,10,Headache,Headaches NEC,Headaches,Nerv,N
889,11,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,Y
889,12,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
889,13,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
889,14,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
889,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
889,16,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
889,17,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
889,18,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
890,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
890,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
890,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
890,4,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
890,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
890,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
891,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
891,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
891,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
892,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
893,1,Splenic rupture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
894,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
894,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
895,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
895,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
896,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
896,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
897,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
897,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
898,1,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
898,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
898,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
899,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
900,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
900,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
901,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
901,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
901,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
902,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
903,1,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
903,2,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
904,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
904,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
905,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
905,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
905,3,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
905,4,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
905,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
905,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
905,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
905,8,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
905,9,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
905,10,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
905,11,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
905,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
905,13,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
905,14,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
905,15,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
905,16,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
906,1,Glioblastoma multiforme,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
907,1,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
907,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
908,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
908,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
909,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
909,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
909,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
909,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
909,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
910,1,Headache,Headaches NEC,Headaches,Nerv,N
910,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
910,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
911,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
911,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
911,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
911,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
912,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
913,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
913,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
913,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
913,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
914,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
915,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
916,1,Glioblastoma multiforme,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
917,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
917,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
918,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
918,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
918,3,Headache,Headaches NEC,Headaches,Nerv,N
918,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
918,5,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
918,6,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
918,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
919,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
920,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
921,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
922,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
922,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
923,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
924,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
924,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
925,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
926,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
926,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
927,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
927,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
927,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
928,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
929,1,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
930,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
931,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
931,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
932,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
932,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
933,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
934,1,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
934,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
934,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
935,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
936,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
936,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
937,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
937,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
938,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
938,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
939,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
940,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
941,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
942,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
943,1,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
944,1,Cardiac failure chronic,Heart failures NEC,Heart failures,Card,N
945,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
945,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
945,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
945,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
946,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
946,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
946,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
947,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
947,2,Pregnancy of partner,Family and partner issues,Family issues,SocCi,N
948,1,Exposure via partner,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
948,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
948,3,Penile swelling,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
949,1,Endometrial cancer stage III,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
950,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
951,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
951,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
952,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
952,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
953,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
953,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
954,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
955,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
955,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
956,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
956,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
956,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
956,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
956,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
957,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
958,1,Nasal polyps,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
958,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
958,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
959,1,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
959,2,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
960,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
960,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
961,1,Headache,Headaches NEC,Headaches,Nerv,N
961,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
961,3,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
961,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
962,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
962,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
962,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
962,4,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
962,5,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
962,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
963,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
963,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
963,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
963,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
963,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
963,6,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
964,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
965,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
965,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
965,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
966,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
967,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
967,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
967,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
968,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
969,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
969,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
969,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
969,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
969,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
970,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
970,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
970,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
971,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
971,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
971,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
972,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
973,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
973,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
974,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
975,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
975,2,Ovarian adenoma,Ovarian neoplasms benign,Reproductive neoplasms female benign,Neopl,N
976,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
977,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
977,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
977,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
978,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
978,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
978,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
979,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
979,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
979,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
979,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
979,5,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
980,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
980,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
980,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
980,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
981,1,Basilar artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
981,2,Locked-in syndrome,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
981,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
981,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
981,5,Vertebral artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
982,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
983,1,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
983,2,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
983,3,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
983,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
983,5,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,N
983,6,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
983,7,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
983,8,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
983,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
984,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
984,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
985,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
986,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
986,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
987,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
987,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
988,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
989,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
990,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
991,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
991,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
991,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
991,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
992,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
992,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
993,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
993,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
994,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
994,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
995,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
995,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
996,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
996,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
997,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
997,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
998,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
998,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
999,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1000,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1001,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1002,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1003,1,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1003,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1003,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1004,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1004,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1004,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1004,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1005,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1005,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1005,3,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1006,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
1006,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1006,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1007,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1008,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1008,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1009,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1010,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1011,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1011,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1011,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1011,4,Headache,Headaches NEC,Headaches,Nerv,N
1011,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1011,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1012,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1013,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1013,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1013,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1013,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1014,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1014,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1015,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1016,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1016,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1016,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1017,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1017,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1017,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1017,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1017,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1018,1,Blood cholesterol abnormal,Cholesterol analyses,Lipid analyses,Inv,N
1018,2,Blood triglycerides abnormal,Triglyceride analyses,Lipid analyses,Inv,N
1018,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1018,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1018,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1018,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1019,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1019,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1019,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1019,4,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1019,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1019,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1020,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1020,2,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,Y
1021,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1021,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1022,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1023,1,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1023,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1023,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1024,1,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
1024,2,Mucosal disorder,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1024,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1024,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1024,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1025,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1026,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1027,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1027,2,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1027,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1027,4,Suprapubic pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1027,5,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1028,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
1028,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1028,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1028,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1028,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1028,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1028,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1028,8,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1028,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1028,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1029,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1029,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1029,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1029,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1029,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1029,6,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1029,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1030,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1031,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1032,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1032,2,Pharyngeal hypoaesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1032,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1033,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
1033,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1034,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1034,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1034,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1035,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1035,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1036,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1037,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1037,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1037,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1038,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1038,2,Oral pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1038,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1038,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1038,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1038,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1039,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1040,1,Lymphoplasmacytoid lymphoma/immunocytoma,Lymphoplasmacytoid lymphomas/immunocytomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1040,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1041,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1041,2,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1042,1,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1043,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1043,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,Y
1044,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1044,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1044,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1045,1,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1045,2,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1045,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1046,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
1047,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1048,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1049,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1049,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1050,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1051,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1052,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1052,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1052,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1053,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1053,2,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1053,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1054,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1055,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1055,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1055,3,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
1055,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1055,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1055,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1056,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1057,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1058,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1059,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
1059,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1059,3,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,Y
1059,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1060,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1061,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1061,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1061,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1061,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1061,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1061,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1062,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1063,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1063,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1063,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1063,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1063,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1063,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1064,1,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1065,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1065,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1065,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1065,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1065,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1065,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1065,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1065,8,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1065,9,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1065,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1065,11,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1066,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1066,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1067,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1067,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1067,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1067,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1068,1,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1069,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1069,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1069,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1070,1,Cytomegalovirus oesophagitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1070,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1070,3,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1070,4,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1070,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1070,6,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1071,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1071,2,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1072,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1072,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1072,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1073,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1073,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1073,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1074,1,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1075,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1075,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1076,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
1077,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1078,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1079,1,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1080,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1081,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1081,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
1082,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1082,2,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1082,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1083,1,Antineutrophil cytoplasmic antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1083,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1083,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1083,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1083,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1084,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
1084,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1085,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1086,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1087,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1088,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1089,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1089,2,Breast cancer recurrent,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1089,3,Lymphangiosis carcinomatosa,Metastases to specified sites,Metastases,Neopl,N
1089,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1090,1,Ear pruritus,Ear disorders NEC,Aural disorders NEC,Ear,N
1090,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1090,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1090,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1090,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1091,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1091,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1091,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1091,4,Headache,Headaches NEC,Headaches,Nerv,N
1092,1,Headache,Headaches NEC,Headaches,Nerv,N
1092,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1093,1,Malignant melanoma stage I,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1094,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1094,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1095,1,Headache,Headaches NEC,Headaches,Nerv,N
1095,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1096,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1097,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1098,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1099,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1099,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1099,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1099,4,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1099,5,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1099,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1100,1,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1101,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1101,2,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
1102,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1102,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1102,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1103,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1103,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1104,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1105,1,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1106,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1106,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1107,1,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1108,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1109,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1110,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1111,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1111,2,Anti-erythrocyte antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
1112,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1112,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1112,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1112,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1112,5,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1112,6,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1112,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1112,8,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1112,9,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1113,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1114,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1115,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1116,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1116,2,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1116,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1116,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1117,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1118,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1119,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1119,2,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1120,1,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1120,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1121,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1122,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1122,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1123,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1124,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1125,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1126,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1127,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1128,1,Type III immune complex mediated reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1129,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1130,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1130,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1131,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1131,2,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1132,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
1133,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
1133,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1133,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1133,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1134,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1134,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1134,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1134,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1134,5,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1134,6,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1134,7,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1134,8,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1134,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1134,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1134,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1134,12,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1134,13,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1135,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1135,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1135,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1135,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1135,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1135,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1135,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1135,8,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1136,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1136,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1136,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1137,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
1138,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1139,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1140,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1140,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1140,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1141,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1141,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1142,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1143,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1143,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1144,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1144,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1145,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1146,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1147,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1148,1,Eosinophilic pustular folliculitis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1148,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1148,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1149,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1150,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1150,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1151,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1151,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1152,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1152,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1152,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1153,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1154,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1155,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1155,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1156,1,Headache,Headaches NEC,Headaches,Nerv,N
1156,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1156,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1157,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1158,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1158,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1158,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1158,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1159,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1159,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1159,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1160,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1160,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1160,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1160,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1160,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1161,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
1161,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1161,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1161,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1161,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1162,1,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1162,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1163,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1164,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1164,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1165,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1165,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1165,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1165,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1165,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1165,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1165,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1165,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1166,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1166,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1167,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1168,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1168,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1169,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1169,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1170,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1171,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1172,1,Malignant neoplasm of unknown primary site,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1173,1,Acne,Acnes,Skin appendage conditions,Skin,N
1174,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1174,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1175,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1176,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1176,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1177,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1177,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1177,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1178,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1178,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1178,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1178,4,Red blood cell abnormality,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
1178,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1179,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1180,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1180,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1180,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1181,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1182,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1182,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1182,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1182,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1183,1,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1183,2,Eczema nummular,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1184,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1184,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1184,3,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1184,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1184,5,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1184,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1185,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1186,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1186,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1186,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1186,4,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
1186,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1186,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1186,7,Headache,Headaches NEC,Headaches,Nerv,N
1186,8,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1186,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1186,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1186,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1186,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1186,13,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1187,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1187,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1188,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1188,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1188,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
1188,4,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1189,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1190,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1190,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1190,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1190,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1190,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1191,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1192,1,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1193,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1194,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1194,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1195,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1195,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1195,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1195,4,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
1195,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1195,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1195,7,Headache,Headaches NEC,Headaches,Nerv,N
1195,8,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1195,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1195,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1195,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1195,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1195,13,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1196,1,Headache,Headaches NEC,Headaches,Nerv,N
1196,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1196,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1196,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1197,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1197,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1197,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1198,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1198,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1198,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1198,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1198,5,Post inflammatory pigmentation change,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1198,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1198,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1198,8,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1198,9,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
1198,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1198,11,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1199,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1199,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1200,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1200,2,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
1200,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
1200,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1200,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1200,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1201,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1201,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1201,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1202,1,Lentigo maligna,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1203,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1204,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1205,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1205,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1205,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1206,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1207,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1208,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1208,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1209,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1209,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1209,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1209,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1210,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1211,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1212,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1213,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1214,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1214,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1215,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1215,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1216,1,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
1217,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1217,2,Headache,Headaches NEC,Headaches,Nerv,N
1217,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1218,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1219,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1220,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1220,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1220,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1220,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1220,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1220,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1220,7,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1220,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1220,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1220,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1220,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1220,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1221,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1221,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1222,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1222,2,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1222,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1222,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1223,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1223,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1223,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1224,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1224,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1225,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1225,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1226,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1227,1,Diffuse alopecia,Alopecias,Skin appendage conditions,Skin,N
1228,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1229,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1230,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1230,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
1231,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1231,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1232,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1233,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1234,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1234,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1234,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1235,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1235,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1235,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1235,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1235,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1235,6,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1236,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1237,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1238,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1238,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1238,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1238,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1238,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1239,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1240,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1240,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1241,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1241,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1242,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1243,1,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,Y
1244,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1245,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1246,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1247,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1248,1,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1248,2,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1248,3,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1248,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1248,5,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
1248,6,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1248,7,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1249,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1249,2,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1250,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1251,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1252,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1253,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1253,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1253,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1253,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1253,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1254,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1254,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1255,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1255,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1255,3,Ventricular failure,Heart failures NEC,Heart failures,Card,N
1256,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1256,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1257,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1257,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1258,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1259,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1259,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1260,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1260,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1260,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1260,4,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1260,5,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1260,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1260,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1260,8,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1261,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1261,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1262,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1262,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1262,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1263,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1263,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1263,3,Headache,Headaches NEC,Headaches,Nerv,N
1263,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1263,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1264,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
1265,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1265,2,Jaw fracture,"Skull fractures, facial bone fractures and dislocations",Bone and joint injuries,Inj&P,N
1266,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1267,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1267,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1267,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1267,4,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1267,5,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1267,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1267,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1267,8,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1268,1,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
1269,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1269,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1269,3,Headache,Headaches NEC,Headaches,Nerv,N
1269,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1269,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1270,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1270,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1271,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1272,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1273,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
1274,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1274,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1275,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1275,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1276,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1277,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1278,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1279,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1279,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1279,3,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1280,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1280,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1280,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1280,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1280,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1280,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1280,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1280,8,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1280,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1281,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1282,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1282,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1282,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1283,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1284,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1284,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1284,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1284,4,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
1284,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1284,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1285,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1285,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1285,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1286,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1286,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1287,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1287,2,Acanthosis,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1287,3,Extravasation blood,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1287,4,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
1287,5,Mucosal disorder,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1287,6,Neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1287,7,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1287,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1287,9,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1287,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1287,11,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1287,12,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
1287,13,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1288,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
1288,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1288,3,Stenotrophomonas sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
1289,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1290,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1290,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1291,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1292,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1292,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1292,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1292,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1292,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1292,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1292,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1293,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1293,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1294,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1295,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1296,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
1296,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1296,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1297,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1298,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1298,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1299,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1299,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1300,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1300,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1300,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1300,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1300,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1301,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1302,1,Squamous cell carcinoma of the tongue,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1303,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1303,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1304,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1305,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1306,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1306,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1306,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1306,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1306,5,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
1307,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1307,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1307,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1307,4,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1308,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1308,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1308,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1309,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1310,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1311,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1312,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1313,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
1314,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1314,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1315,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1315,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1315,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1315,4,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1316,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1316,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1317,1,Testicular neoplasm,Reproductive neoplasms male unspecified malignancy,Reproductive neoplasms male malignant and unspecified,Neopl,N
1318,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1318,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1318,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1318,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1318,5,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1318,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1319,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1320,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1321,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
1322,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1323,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1324,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1325,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1325,2,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1326,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1326,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1326,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1326,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1326,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1326,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1326,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1327,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1328,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1329,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1330,1,Vaginal fistula,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1331,1,Blood immunoglobulin M increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1332,1,Idiopathic environmental intolerance,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1333,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1333,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1333,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1333,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1334,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1334,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1334,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1334,4,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1334,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1334,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1334,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1335,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1335,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1336,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1336,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1337,1,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1337,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1337,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1337,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1337,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1337,6,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1337,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1337,8,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1337,9,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1337,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1337,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1337,12,Peripheral T-cell lymphoma unspecified recurrent,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
1337,13,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1337,14,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1337,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1338,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1338,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1338,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1338,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1339,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1339,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1339,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1339,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1339,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1339,6,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1339,7,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1339,8,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1339,9,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1339,10,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1339,11,Headache,Headaches NEC,Headaches,Nerv,N
1339,12,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1339,13,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1339,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1339,15,Migraine,Migraine headaches,Headaches,Nerv,N
1339,16,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1339,17,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1339,18,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1339,19,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1339,20,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1339,21,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1339,22,Visual field defect,Visual field disorders,Vision disorders,Eye,N
1339,23,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1339,24,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1340,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,Y
1341,1,Hypergammaglobulinaemia benign monoclonal,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
1342,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1342,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1343,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1343,2,Vitreoretinal traction syndrome,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1344,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1344,2,Headache,Headaches NEC,Headaches,Nerv,N
1344,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1345,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1346,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1346,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1346,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1347,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1348,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1348,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1348,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1348,4,Red cell distribution width decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1348,5,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1348,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1349,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1349,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1349,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1349,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1349,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1349,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1350,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1350,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1350,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1350,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1350,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1351,1,Ecthyma,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1352,1,Macular hole,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1352,2,Vitreoretinal traction syndrome,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1353,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1353,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1354,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1354,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1355,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1355,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1356,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1356,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1356,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1357,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1357,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1357,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1357,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1357,5,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1357,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1357,7,Protein-losing gastroenteropathy,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1358,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1359,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1360,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1360,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1360,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1361,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1361,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1362,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1362,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1362,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1362,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1363,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1364,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1364,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1365,1,B-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1366,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1366,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1367,1,Congenital musculoskeletal disorder of skull,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1367,2,Congenital nose malformation,Nasal disorders congenital,Respiratory disorders congenital,Cong,N
1367,3,Dysmorphism,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
1367,4,Prominent epicanthal folds,Eyelid disorders congenital,Eye disorders congenital,Cong,N
1368,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1368,2,Blood immunoglobulin M decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1369,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1370,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1370,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1371,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1371,2,Headache,Headaches NEC,Headaches,Nerv,N
1371,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1371,4,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1371,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1371,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1371,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1372,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1373,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1374,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1374,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1375,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1375,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1375,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1376,1,Angiodermatitis,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
1376,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1376,3,Electrocardiogram change,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1376,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1376,5,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1377,1,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
1378,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1378,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1378,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1378,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1378,5,Duodenal stenosis,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1378,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1378,7,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1378,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1378,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1378,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1379,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1380,1,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
1381,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1381,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1382,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1382,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1383,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1384,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1385,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
1386,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1386,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1386,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1387,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1388,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1389,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1389,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1389,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1389,4,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1390,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1391,1,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1392,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1392,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1392,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1392,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1393,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1394,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1395,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1396,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1396,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1396,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1396,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1397,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1397,2,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1398,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1399,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1399,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1399,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1400,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1400,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1400,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1400,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1400,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1401,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1401,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1401,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1402,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1402,2,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1402,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1403,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1404,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1404,2,Appendiceal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1404,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1405,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1406,1,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1406,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1407,1,Apallic syndrome,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1407,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1407,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1407,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1407,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1407,6,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1407,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1407,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1407,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1408,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1408,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1408,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1409,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1409,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1409,3,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1409,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1410,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1411,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1411,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1412,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1412,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1413,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1413,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1414,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1414,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1415,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1415,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1415,3,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,Y
1415,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1415,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1415,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1416,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1417,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1417,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1417,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1418,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1418,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1418,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1419,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1419,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1419,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1419,4,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1419,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1420,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1420,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1420,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1421,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1421,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1422,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1423,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1424,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1424,2,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1424,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1424,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1425,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1425,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1426,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1426,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1427,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1428,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1428,2,Headache,Headaches NEC,Headaches,Nerv,N
1428,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1429,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1429,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1430,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1431,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1432,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1432,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1432,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1432,4,Leukodystrophy,Lysosomal storage disorders,Metabolic and nutritional disorders congenital,Cong,N
1432,5,Leukodystrophy,Lysosomal storage disorders,Metabolic and nutritional disorders congenital,Cong,N
1432,6,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1432,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1433,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1433,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1434,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1435,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1436,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1436,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1436,3,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1437,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1437,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1437,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1438,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1438,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1438,3,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1439,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1439,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1439,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1440,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1441,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1442,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1443,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1444,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1444,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1444,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1444,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1444,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1444,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1444,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1444,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1444,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1444,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1444,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1444,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1445,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1446,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1447,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1447,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1448,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1448,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1449,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1450,1,Engraft failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1450,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1450,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1450,4,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1451,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1452,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1452,2,Engraft failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1452,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1452,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1453,1,Foetal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1453,2,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1454,1,Carotid artery aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
1454,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1454,3,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1454,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1454,5,Microembolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1455,1,ADAMTS13 activity decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1455,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1455,3,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1455,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1455,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1455,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1455,7,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
1456,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1456,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1457,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1458,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1458,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1458,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1458,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1458,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1459,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1459,2,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1459,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1460,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1460,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1460,3,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1461,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1461,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1461,3,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
1461,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1461,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1461,6,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1462,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1462,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1462,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1462,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1462,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1463,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1463,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1463,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1464,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1464,2,Renal mass,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1465,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1465,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1465,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1466,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1467,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1467,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1467,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1468,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1469,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1470,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1470,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1470,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1470,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1471,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1471,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1472,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1472,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1472,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1473,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1473,2,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
1473,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1473,4,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1473,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1473,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1473,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1474,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1474,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1474,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1475,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1476,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1476,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1476,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1476,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1477,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1477,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
1478,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1478,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1479,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1480,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1480,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1480,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1480,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1480,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1480,6,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1480,7,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1480,8,Hepatitis B DNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
1480,9,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
1480,10,Hepatitis B surface antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1480,11,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1480,12,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1480,13,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1480,14,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1480,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1481,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1481,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1481,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1481,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
1481,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1482,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1483,1,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
1484,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1485,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1486,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,Y
1487,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1487,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1488,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1489,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1489,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1489,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1489,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1489,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1489,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1490,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1490,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1490,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1490,4,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
1491,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1491,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1491,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1491,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1491,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1491,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1491,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1492,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1493,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1493,2,Urticaria chronic,Urticarias,Angioedema and urticaria,Skin,N
1494,1,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1495,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1495,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1496,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1497,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1498,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1499,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1499,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1500,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1500,2,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
1501,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1502,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1503,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1503,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1503,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1503,4,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1503,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1503,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1504,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1504,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,Y
1504,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1505,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1505,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1505,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1505,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1505,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1506,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1506,2,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1506,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1507,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1508,1,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1509,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1509,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1510,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1511,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1512,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1513,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1514,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1514,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1515,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1515,2,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
1515,3,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1515,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1516,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1516,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1516,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1517,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1518,1,Dermatitis infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1519,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1520,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1521,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1522,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1522,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1522,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1522,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1522,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1523,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1523,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1523,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1523,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1523,5,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1523,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1523,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1523,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1523,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1523,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1524,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1525,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1526,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1526,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
1527,1,Blood glucagon decreased,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
1527,2,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1528,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1528,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1528,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1528,4,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1528,5,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1529,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1529,2,Urogenital haemorrhage,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
1530,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1530,2,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1531,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1531,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1532,1,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,N
1533,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1533,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1534,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1534,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1535,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1535,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1535,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1536,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1536,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1536,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1536,4,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1536,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,Y
1536,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1536,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1536,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1536,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1536,10,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1536,11,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1537,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1538,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1538,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1539,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1539,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1539,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1540,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1540,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1540,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1540,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1541,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1542,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1542,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1542,3,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1542,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1543,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1544,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1545,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1546,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
1547,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
1547,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1548,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1548,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1548,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1548,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1548,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1549,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1550,1,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1551,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1552,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1552,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1553,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1554,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1554,2,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
1555,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1556,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1557,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1558,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1558,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1559,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1560,1,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
1560,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1561,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1562,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1562,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1562,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1562,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1562,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1562,6,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
1563,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1563,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1563,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1563,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1563,5,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1563,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1563,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1563,8,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1563,9,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
1563,10,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1564,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1564,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1565,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
1565,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1566,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1566,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1566,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1566,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1566,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1567,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1568,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1568,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1569,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1570,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1571,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1571,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1571,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1571,4,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1571,5,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
1571,6,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1571,7,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
1571,8,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1571,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1571,10,Meningoencephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1571,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1571,12,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1571,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1572,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1573,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1574,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1574,2,Headache,Headaches NEC,Headaches,Nerv,N
1574,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1574,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1575,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1575,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1576,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1576,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1576,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1577,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1578,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1578,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1578,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1579,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1579,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1579,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1579,4,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1579,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1579,6,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1579,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1580,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1580,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1580,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1581,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1581,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1581,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1581,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1582,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1582,2,Tension headache,Headaches NEC,Headaches,Nerv,N
1583,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1583,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1584,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1584,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1585,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1586,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1586,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1587,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1587,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1588,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1588,2,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1589,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1589,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1589,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1590,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1591,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1591,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1591,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1591,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1592,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1592,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1593,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1593,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1594,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1594,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1594,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1594,4,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1594,5,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1594,6,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1594,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1594,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1594,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1594,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1594,11,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1594,12,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1594,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1595,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1595,2,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1595,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1595,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1595,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1596,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1596,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1596,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1596,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1596,5,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1596,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1597,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1597,2,Hairy cell leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
1597,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1598,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1598,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1599,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1600,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1601,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1601,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1602,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1603,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
1604,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1604,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1604,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1605,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1605,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1605,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1606,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1607,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1608,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1608,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1609,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1610,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1611,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1611,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1612,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1612,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1612,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1612,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1612,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1613,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1613,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1614,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1615,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1615,2,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1615,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1615,4,Headache,Headaches NEC,Headaches,Nerv,N
1615,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1616,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1616,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1616,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1616,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1616,5,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1616,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1617,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1618,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1618,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1618,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1618,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1619,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1619,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1619,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1620,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1620,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1620,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1620,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1620,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1621,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1621,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1621,3,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1622,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1622,2,Herpes zoster disseminated,Herpes viral infections,Viral infectious disorders,Infec,N
1622,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1622,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1623,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1624,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1625,1,Hypergammaglobulinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
1626,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1627,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1627,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1628,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1628,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1628,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1628,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1629,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1630,1,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
1630,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1630,3,Neuropsychological symptoms,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
1630,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1630,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1631,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1631,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1631,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1631,4,Polyp,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1632,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1632,2,Headache,Headaches NEC,Headaches,Nerv,N
1632,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1632,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1632,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1632,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1633,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1634,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1635,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1636,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1637,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1638,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1639,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1640,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1641,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1642,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1643,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1644,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1645,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1646,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1646,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1647,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1647,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1647,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1647,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1647,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1647,6,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1647,7,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1648,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1649,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1649,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1649,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1650,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1650,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1651,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1651,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1651,3,JC polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1651,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1651,5,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1651,6,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1651,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1652,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1652,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1653,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1653,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1654,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1655,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1656,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1657,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1657,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1658,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1658,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1658,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1658,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1659,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1659,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1659,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1660,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1661,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1661,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1661,3,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1662,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1662,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1662,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1662,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1662,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1663,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1663,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1663,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1664,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1665,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1666,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1667,1,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
1668,1,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
1668,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
1669,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1670,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1670,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1671,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1671,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1671,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1671,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1671,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1672,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1672,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1673,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1673,2,Cytokine storm,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1673,3,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1674,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1674,2,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1675,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1675,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1675,3,Headache,Headaches NEC,Headaches,Nerv,N
1675,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1675,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1676,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1676,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1677,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1678,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1678,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1678,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1678,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1678,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1678,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1678,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1678,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1678,9,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1679,1,Hernia pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1679,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1679,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1680,1,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1681,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1681,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1681,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1681,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1682,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1683,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1683,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1683,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1683,4,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
1684,1,Cervix carcinoma stage I,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1685,1,Headache,Headaches NEC,Headaches,Nerv,N
1685,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1685,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1686,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1686,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1687,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1687,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1687,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1688,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1689,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1689,2,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1689,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1689,4,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1689,5,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1690,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
1691,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1692,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1693,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1694,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1694,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1694,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1694,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1694,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1694,6,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1695,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1696,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1697,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1698,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1699,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1700,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1701,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1702,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1703,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1704,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1705,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1706,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1707,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1708,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1709,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1710,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1711,1,Perinephric abscess,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1712,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1713,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1714,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1714,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1714,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1715,1,Blood luteinising hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1715,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1715,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1716,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1716,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1716,3,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1716,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1716,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1716,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1716,7,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1717,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1717,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1718,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1718,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1718,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1719,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1719,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1720,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1721,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1721,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1721,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1721,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1722,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1723,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1723,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1723,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
1723,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1723,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1723,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1724,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1724,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1724,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1725,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1726,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1726,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1727,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1727,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1728,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1728,2,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
1729,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1730,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1730,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1730,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1730,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1730,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1731,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1731,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1731,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1732,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1733,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1733,2,Dementia with Lewy bodies,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1733,3,Frontotemporal dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1733,4,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1733,5,Progressive bulbar palsy,Motor neurone diseases,Neuromuscular disorders,Nerv,N
1734,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1735,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1736,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1736,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1736,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1736,4,Hairy cell leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
1736,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1736,6,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1736,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1736,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1737,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1737,2,Headache,Headaches NEC,Headaches,Nerv,N
1737,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1738,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1738,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1739,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1739,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1740,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
1740,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1740,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1740,4,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1740,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1740,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1740,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1740,8,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1740,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1740,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1740,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1740,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1741,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1742,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1742,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1742,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1742,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1742,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1743,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1744,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1744,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1744,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1745,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1746,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1746,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1746,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1746,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1747,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1747,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1747,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1747,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1747,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1748,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1749,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
1749,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1750,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1750,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1750,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1750,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1750,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1751,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1751,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1752,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1752,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1752,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1752,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1752,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1752,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1753,1,Hepatitis B virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1754,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1755,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1755,2,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1755,3,Migraine,Migraine headaches,Headaches,Nerv,N
1755,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1756,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1756,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1756,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1757,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1757,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1757,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1757,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1758,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1759,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1759,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1759,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1760,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1760,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1760,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1760,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1761,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1761,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1761,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1761,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1761,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1762,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1763,1,Gingival discolouration,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1763,2,Headache,Headaches NEC,Headaches,Nerv,N
1763,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1763,4,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1763,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1763,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1763,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1763,8,Tooth avulsion,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1764,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1764,2,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
1764,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1764,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1764,5,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
1764,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1765,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
1766,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1766,2,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1767,1,Acute lung injury,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1767,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1768,1,Blood immunoglobulin M increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1769,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1770,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1770,2,Disseminated varicella zoster vaccine virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
1770,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1771,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
1771,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1771,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1772,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1773,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1774,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1775,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1776,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1777,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1777,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1778,1,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1778,2,Paternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1779,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1780,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1780,2,Cytokine storm,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1780,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1781,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1782,1,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1782,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1783,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1784,1,"Follicle centre lymphoma, follicular grade I, II, III recurrent",Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1784,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1785,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1785,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1785,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1785,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1785,5,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1785,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1785,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1786,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1786,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1786,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1787,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1788,1,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,N
1789,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1789,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1789,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1789,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1789,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1789,6,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1790,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1791,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1792,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1793,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1793,2,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1794,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1795,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1796,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1796,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1796,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1796,4,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1796,5,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1796,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1796,7,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
1797,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1798,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1798,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1799,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1799,2,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1800,1,Non-Hodgkin's lymphoma recurrent,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1801,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1802,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1802,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1802,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1802,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1803,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1803,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1804,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1805,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1805,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1806,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1807,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1808,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1809,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1809,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1809,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1809,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1809,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1809,6,Disability,Disability issues,Lifestyle issues,SocCi,N
1809,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1809,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1809,9,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1809,10,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1809,11,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
1809,12,Ligament disorder,Ligament disorders,"Tendon, ligament and cartilage disorders",Musc,N
1809,13,Lymphatic obstruction,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1809,14,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1809,15,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1809,16,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1809,17,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1809,18,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1809,19,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1809,20,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1809,21,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1809,22,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1809,23,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1809,24,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1809,25,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1809,26,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1809,27,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1810,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1810,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1811,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1812,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1813,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1814,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1815,1,Amyloidosis,Amyloidoses,Immune disorders NEC,Immun,N
1815,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1815,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1816,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1816,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1816,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1817,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1817,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1817,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1817,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1817,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1818,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1819,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1819,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1819,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1819,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1819,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1819,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1819,7,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
1819,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1819,9,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1819,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1819,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1820,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1820,2,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1821,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1821,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1821,3,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1821,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1821,5,Extramedullary haemopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
1821,6,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1821,7,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1821,8,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1821,9,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1821,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1821,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1821,12,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1821,13,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1821,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
1822,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1822,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1822,3,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1822,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1822,5,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1822,6,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1822,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1822,8,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1822,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1822,10,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1822,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1822,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1823,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1823,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1823,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1824,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1825,1,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1826,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1827,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
1828,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1829,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,Y
1830,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1831,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1831,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1832,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1832,2,Pulmonary alveolar haemorrhage,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1833,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1834,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1834,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1835,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1835,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1836,1,Otitis media bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1836,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1836,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1836,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1836,5,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
1837,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1837,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1837,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1838,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1838,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1838,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1839,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1840,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1841,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1841,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1841,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1842,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1842,2,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1843,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1843,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1844,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1844,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1844,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1844,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1845,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1846,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1847,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1847,2,Lesion excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1848,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1848,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1848,3,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1848,4,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1849,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1849,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1849,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1849,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1849,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1850,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1850,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1850,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1850,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1850,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1851,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1852,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1852,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1853,1,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
1854,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1855,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1855,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1855,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1856,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1856,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1857,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1857,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1857,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1858,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1859,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1859,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1860,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1860,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1860,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1861,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1861,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1862,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1863,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1863,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1864,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1865,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1865,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1865,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1866,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1866,2,Herpes zoster oticus,Herpes viral infections,Viral infectious disorders,Infec,N
1866,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1866,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1867,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1868,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1868,2,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1868,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
1868,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1868,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1868,6,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1868,7,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1868,8,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1869,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1870,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1870,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1870,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1870,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1870,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1870,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1870,7,Glassy eyes,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1870,8,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1871,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1871,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1872,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1873,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1874,1,Viral cardiomyopathy,Viral infections NEC,Viral infectious disorders,Infec,N
1875,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1875,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1875,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1875,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1875,5,Complement factor C3 decreased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
1875,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1875,7,Glomerulonephritis rapidly progressive,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1875,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1875,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1875,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1875,11,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1875,12,Red blood cells urine positive,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1876,1,Anterograde amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1876,2,B-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1876,3,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1876,4,Human herpesvirus 6 infection reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
1876,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1876,6,Pleocytosis,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1877,1,Anterograde amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1877,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1877,3,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1877,4,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1877,5,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1877,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1877,7,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
1877,8,Encephalitis herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1877,9,Headache,Headaches NEC,Headaches,Nerv,N
1877,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1877,11,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1877,12,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1877,13,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1877,14,Pleocytosis,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1877,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1877,16,Simple partial seizures,Partial simple seizures NEC,Seizures (incl subtypes),Nerv,N
1878,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1878,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1879,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1879,2,Viral cardiomyopathy,Viral infections NEC,Viral infectious disorders,Infec,N
1880,1,Anterograde amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1880,2,Encephalitis herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1880,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1881,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1881,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1881,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1882,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1883,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1884,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1885,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1885,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1885,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1886,1,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1887,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1888,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1888,2,Biliary tract infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,Y
1888,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1889,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1890,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1890,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1890,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1891,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1891,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1891,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1891,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1891,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1891,6,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1892,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1893,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1894,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1895,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
1896,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1896,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1897,1,Aortic valve incompetence,Aortic valvular disorders,Cardiac valve disorders,Card,N
1897,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1898,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1898,2,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1898,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1898,4,Splinter haemorrhages,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1899,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1899,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1900,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1901,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1901,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1901,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1901,4,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1901,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1901,6,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
1902,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1902,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1903,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1903,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1903,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1903,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1903,5,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1903,6,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1903,7,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1904,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1904,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1905,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1906,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1906,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1906,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1906,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1906,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1906,6,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1906,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1906,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1906,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1907,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1907,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1908,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1908,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1908,3,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1908,4,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1909,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1909,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1910,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1910,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1911,1,Meningitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1912,1,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1912,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1912,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1913,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1913,2,Aortic valve incompetence,Aortic valvular disorders,Cardiac valve disorders,Card,N
1913,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1913,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1913,5,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1913,6,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1913,7,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
1914,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1914,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1914,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1914,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1915,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1915,2,Consciousness fluctuating,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1915,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1916,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1916,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1917,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1918,1,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1918,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1918,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1918,4,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1918,5,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1919,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1919,2,Legionella infection,Legionella infections,Bacterial infectious disorders,Infec,N
1919,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1919,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1919,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1919,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1920,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1920,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1920,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1921,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1922,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1923,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1923,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1923,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1923,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1923,5,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1924,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1924,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1924,3,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1924,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1924,5,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1924,6,Concomitant disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1924,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1924,8,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1924,9,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1925,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1925,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1925,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1925,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1925,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1926,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1926,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1926,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1926,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1927,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1927,2,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1927,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1927,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1927,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1927,6,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1927,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1927,8,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1927,9,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1927,10,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1927,11,Renal vasculitis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1927,12,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1927,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1928,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1928,2,Postoperative respiratory distress,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1929,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1930,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1931,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1931,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1932,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1932,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1932,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1932,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1932,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1932,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1932,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1932,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1932,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1932,10,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1932,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1933,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1934,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1934,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1934,3,Headache,Headaches NEC,Headaches,Nerv,N
1934,4,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1934,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1934,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1935,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1935,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1935,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1935,4,Headache,Headaches NEC,Headaches,Nerv,N
1935,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1935,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1935,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1935,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1935,9,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1935,10,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1935,11,Serum sickness-like reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1935,12,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1936,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1936,2,Headache,Headaches NEC,Headaches,Nerv,N
1936,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1936,4,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1936,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1936,6,Serum sickness-like reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1936,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1937,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1937,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1937,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1938,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1938,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1938,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1938,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1939,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1939,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1940,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1940,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1941,1,Antisynthetase syndrome,Muscle infections and inflammations,Muscle disorders,Musc,N
1941,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1941,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1941,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1942,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1943,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1944,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1944,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1944,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1944,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1944,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1944,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1944,7,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1945,1,Blood immunoglobulin G,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1946,1,Blood immunoglobulin G,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1947,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1948,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1949,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1949,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1949,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1949,4,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1949,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1949,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1949,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1950,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1951,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1951,2,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1952,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1953,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1953,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1954,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1954,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1954,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1955,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1955,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1955,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1955,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1956,1,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
1957,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1957,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1958,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1958,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1958,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1959,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1959,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1959,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1960,1,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
1960,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1960,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1960,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1961,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1961,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1961,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1962,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1963,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1964,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1965,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1966,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1967,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1968,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1968,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1968,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1969,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1969,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1970,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1970,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1970,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1971,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1972,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1972,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1972,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1973,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1974,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1975,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1976,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1976,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1976,3,Headache,Headaches NEC,Headaches,Nerv,N
1976,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1976,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1976,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1977,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1978,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1979,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1980,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1980,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1980,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1981,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1982,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
1982,2,Hepatitis B e antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1982,3,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
1982,4,Hepatitis B surface antigen positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1982,5,Liver function test decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1982,6,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1983,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1983,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1984,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1985,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1985,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1985,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1985,4,Streptococcal urinary tract infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1986,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1987,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1987,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1987,3,Human rhinovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1987,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1987,5,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1988,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1989,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1989,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1990,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1990,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1991,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1991,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1991,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1991,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1991,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1992,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1992,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1992,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1992,4,Terminal ileitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1993,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1994,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1994,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1994,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1995,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1995,2,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1995,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1995,4,Headache,Headaches NEC,Headaches,Nerv,N
1995,5,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1995,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1995,7,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,Y
1995,8,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1995,9,Tumour necrosis,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
1995,10,Vasogenic cerebral oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1995,11,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1996,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1997,1,Lower respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
1998,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1998,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1998,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1998,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1999,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1999,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1999,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1999,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1999,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2000,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2000,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2000,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2000,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2000,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2000,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2000,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2001,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2001,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2002,1,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2002,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2002,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2003,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2003,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2004,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2004,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2004,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2004,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2005,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2006,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2007,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2007,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2007,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2007,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2008,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2008,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2009,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2009,2,Central venous catheterisation,Venous therapeutic procedures,Vascular therapeutic procedures,Surg,N
2009,3,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2009,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2009,5,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
2009,6,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2009,7,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
2009,8,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,N
2009,9,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2009,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2009,11,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2009,12,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2009,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2009,14,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2009,15,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2010,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2010,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2010,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2010,4,Hyporesponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2010,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2010,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2010,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2010,8,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2011,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2011,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2012,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2012,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2012,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2012,4,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2012,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2012,6,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
2012,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2012,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2012,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2012,10,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2012,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2013,1,Cerebellar tumour,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
2014,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
2014,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2014,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2015,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2015,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
2016,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2016,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2016,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2016,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2016,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
2016,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2016,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2017,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2017,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2017,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2017,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2017,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2017,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2018,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2018,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2018,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2019,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2020,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2020,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2021,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2022,1,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2022,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2022,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2022,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2023,1,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
2023,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2024,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2024,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2025,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2025,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2025,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2026,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2026,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2026,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2027,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2028,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2029,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2030,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2030,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2031,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2031,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2032,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2032,2,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2033,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2033,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2033,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2033,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2033,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2034,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2035,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2035,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2036,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2036,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2037,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2037,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
2037,3,Scleral hyperaemia,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2038,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2038,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2039,1,Headache,Headaches NEC,Headaches,Nerv,N
2039,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2039,3,Product substitution,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2040,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2040,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2041,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2041,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2041,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2041,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2042,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2042,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2042,3,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2042,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
2043,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2043,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2043,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2043,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2044,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2044,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2044,3,Headache,Headaches NEC,Headaches,Nerv,N
2044,4,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2044,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2045,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2045,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2045,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2045,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2045,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2046,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
2046,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2047,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2047,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2047,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2047,4,Chronic graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2047,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2047,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2047,7,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2047,8,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2047,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2047,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2047,11,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
2047,12,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
2048,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
2048,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2048,3,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
2048,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2048,5,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
2049,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2049,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2049,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2049,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2049,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2049,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2050,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2050,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2050,3,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
2050,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2051,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2051,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2051,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2052,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2052,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2052,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2053,1,Chest expansion decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2053,2,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
2053,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2053,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2054,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2054,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2054,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2054,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2055,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2055,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2055,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
2056,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2056,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2056,3,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,Y
2056,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2057,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2057,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2058,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2058,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2058,3,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
2058,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2058,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2058,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2058,7,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2058,8,Vascular pseudoaneurysm,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2059,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2059,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2059,3,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2060,1,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2060,2,Headache,Headaches NEC,Headaches,Nerv,N
2061,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2061,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2061,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2061,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2061,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2061,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2061,7,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2061,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2061,9,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2062,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2062,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2062,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2063,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
2063,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2064,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2064,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2064,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2065,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2066,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2066,2,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2067,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2067,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2068,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2068,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2069,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2069,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2070,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2070,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2071,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2072,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2072,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2073,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2073,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2074,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2075,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2076,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2076,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2077,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2078,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2078,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2079,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2080,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2081,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2082,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2083,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2084,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2085,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2086,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2087,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2087,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2087,3,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2087,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2088,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2088,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2089,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2089,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2090,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2090,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2091,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2091,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2092,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2092,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2093,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2094,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2094,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2095,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2095,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2096,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2096,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2096,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2096,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2097,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2097,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2098,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2098,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2099,1,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
2099,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2100,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2100,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2100,3,Nodular lymphocyte predominant Hodgkin lymphoma,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,Y
2100,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2101,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2101,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2101,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2102,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2102,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2102,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2102,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
2103,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2103,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2103,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2103,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2103,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2104,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2104,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2104,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2105,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2105,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2105,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2105,4,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,Y
2106,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,Y
2106,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2107,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2107,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2108,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2108,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2108,3,Headache,Headaches NEC,Headaches,Nerv,N
2108,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
2108,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2109,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2109,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2109,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2110,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2110,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2110,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2111,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2111,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2112,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2112,2,Headache,Headaches NEC,Headaches,Nerv,N
2112,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2113,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2113,2,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
2113,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2113,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2113,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2113,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2113,7,Pneumonia adenoviral,Adenoviral infections,Viral infectious disorders,Infec,N
2114,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2114,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2115,1,Headache,Headaches NEC,Headaches,Nerv,N
2115,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2115,3,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2115,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2115,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2116,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2117,1,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
2118,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2118,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2119,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2119,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2119,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2120,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2120,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2120,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2120,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2121,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2121,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2122,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
2123,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2123,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
2124,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2124,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2125,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2125,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2125,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2125,4,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2125,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2126,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2126,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2127,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2127,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2128,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2128,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2128,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2128,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2128,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2128,6,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2128,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2129,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2129,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2130,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2131,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
2131,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2131,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2131,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2132,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2132,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2133,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2133,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2133,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2134,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2134,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2134,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2135,1,Headache,Headaches NEC,Headaches,Nerv,N
2136,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2137,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2137,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2137,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2138,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2138,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2138,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2138,4,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
2138,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2138,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2138,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2139,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2140,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2141,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
2141,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
2142,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2143,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
2144,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2144,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2145,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2145,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2145,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2145,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2145,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2146,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2146,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2146,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
2146,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2146,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2146,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2147,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2147,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2148,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2148,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2148,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2148,4,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
2149,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2150,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2150,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2150,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2150,4,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
2150,5,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2150,6,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2150,7,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2150,8,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2150,9,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2150,10,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2150,11,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2150,12,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2150,13,Headache,Headaches NEC,Headaches,Nerv,N
2150,14,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2150,15,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
2150,16,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2150,17,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2150,18,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2150,19,Migraine,Migraine headaches,Headaches,Nerv,N
2150,20,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2150,21,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2150,22,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2150,23,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2150,24,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
2150,25,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2150,26,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
2150,27,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2150,28,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2150,29,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2151,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
2151,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2151,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2151,4,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2151,5,Postictal state,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2151,6,Streptococcal bacteraemia,Streptococcal infections,Bacterial infectious disorders,Infec,N
2152,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2152,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2152,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2152,4,Tension headache,Headaches NEC,Headaches,Nerv,N
2153,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2154,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2154,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2154,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2154,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2155,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2155,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2156,1,Headache,Headaches NEC,Headaches,Nerv,N
2156,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2157,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2158,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2158,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2159,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2159,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2159,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2160,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2160,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2160,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2161,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
2161,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2161,3,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2162,1,Neuroendocrine carcinoma of the skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,Y
2162,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2162,3,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2163,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2163,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2163,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2163,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2163,5,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2163,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2164,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2164,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2164,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2164,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2165,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2166,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2166,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2166,3,Pneumonia streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
2166,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2167,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2167,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2167,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2168,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2168,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2168,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2169,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2169,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2170,1,Hairy cell leukaemia recurrent,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
2170,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2171,1,Non-Hodgkin's lymphoma refractory,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
2172,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
2172,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2172,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2172,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2172,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2172,6,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2172,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2172,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2173,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2173,2,Nodular vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
2173,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2173,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2173,5,Vasculitic ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2174,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2175,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2176,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2177,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2178,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2178,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2178,3,Headache,Headaches NEC,Headaches,Nerv,N
2178,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2178,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2178,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2178,7,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2179,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2179,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2179,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
2179,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2179,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2180,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2180,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2181,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2181,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2181,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2182,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2182,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2182,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2182,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2182,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2183,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2183,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2183,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2184,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2184,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2185,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2185,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2185,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2185,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2185,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
2185,6,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2186,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2187,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2187,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2188,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2189,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2189,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2189,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2189,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2189,5,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2190,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2190,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2190,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2190,4,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
2190,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2191,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2191,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
2191,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2191,4,Headache,Headaches NEC,Headaches,Nerv,N
2191,5,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2191,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2192,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2192,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2192,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2192,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2193,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
2193,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2193,3,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
2193,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2193,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2193,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2194,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
2194,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2194,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
2194,4,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2194,5,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
2194,6,Pneumonia mycoplasmal,Mycoplasma infections,Mycoplasmal infectious disorders,Infec,N
2194,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2194,8,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
2195,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2195,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2195,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2196,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2196,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2196,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2197,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2197,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2197,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2197,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2197,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2198,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2199,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2199,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2199,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2200,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2200,2,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2201,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2201,2,Headache,Headaches NEC,Headaches,Nerv,N
2201,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2201,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2201,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2201,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2202,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
2202,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
2202,3,Eosinophilic granulomatosis with polyangiitis,Vasculitides,Immune disorders NEC,Immun,N
2202,4,Eosinophilic myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
2202,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2202,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2203,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
2204,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2204,2,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2204,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2204,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2204,5,Product substitution,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2204,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2204,7,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2204,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2205,1,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2206,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2206,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2206,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2206,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
2206,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2206,6,Serum sickness-like reaction,Allergic conditions NEC,Allergic conditions,Immun,N
2207,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2207,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2207,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2207,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2207,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2207,6,Streptococcal bacteraemia,Streptococcal infections,Bacterial infectious disorders,Infec,N
2208,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2208,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2208,3,Eyelid rash,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2209,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
2209,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2209,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2210,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2211,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2211,2,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2211,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
2211,4,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2212,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2212,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2212,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2212,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2212,5,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
2213,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2213,2,Lymph node palpable,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2213,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2213,4,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2214,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2214,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
2214,3,Eosinophilic granulomatosis with polyangiitis,Vasculitides,Immune disorders NEC,Immun,N
2214,4,Eosinophilic myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
2214,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2215,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2216,1,Acne,Acnes,Skin appendage conditions,Skin,N
2216,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2216,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2217,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2217,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2217,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2217,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2217,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2217,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2218,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
2218,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2218,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2218,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2218,5,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2218,6,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
2218,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2218,8,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2218,9,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
2218,10,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2218,11,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2219,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2219,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2219,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2219,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2219,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2219,6,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2219,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2219,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2219,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2219,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2220,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2221,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2221,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2222,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2222,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2223,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2223,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2223,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2223,4,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
2223,5,Meningoencephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2224,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2224,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2224,3,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2224,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2224,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2225,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2226,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
2227,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2228,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2228,2,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2228,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2228,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2228,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2228,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2228,7,Headache,Headaches NEC,Headaches,Nerv,N
2228,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2228,9,Oral blood blister,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
2228,10,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2228,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2228,12,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2228,13,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2229,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2229,2,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
2230,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2231,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2232,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2233,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2233,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2234,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2234,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2234,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2234,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2235,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2235,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2236,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2236,2,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2236,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2236,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2236,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2236,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2236,7,Headache,Headaches NEC,Headaches,Nerv,N
2236,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2236,9,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2236,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2237,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2237,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2237,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2237,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2237,5,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2237,6,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2237,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2237,8,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2238,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2238,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2238,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2238,4,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2239,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2239,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2239,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2239,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2240,1,Therapeutic response changed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2241,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2241,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2242,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2242,2,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2242,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2242,4,Nasal ulcer,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2242,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2243,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2243,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2243,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2243,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2244,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2244,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2244,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2244,4,Headache,Headaches NEC,Headaches,Nerv,N
2245,1,Cutaneous T-cell lymphoma recurrent,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
2246,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2246,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2246,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2246,4,Headache,Headaches NEC,Headaches,Nerv,N
2246,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2246,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2246,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2246,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2246,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2247,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2247,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2247,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2248,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2249,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2249,2,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2249,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2249,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2249,5,Mean cell haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2249,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2249,7,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2249,8,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
2249,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2250,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2250,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2250,3,Right ventricular failure,Right ventricular failures,Heart failures,Card,Y
2251,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2251,2,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2251,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2251,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2251,5,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2251,6,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2251,7,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2251,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2251,9,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2251,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2252,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2252,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2252,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2252,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2252,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2253,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2253,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2253,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2253,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2253,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2254,1,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
2255,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2256,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2256,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2257,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
2257,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
2258,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2258,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2258,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2259,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
2260,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2261,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2262,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2262,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2263,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2263,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2264,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
2265,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
2265,2,Tension headache,Headaches NEC,Headaches,Nerv,N
2266,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2266,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2266,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2266,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2267,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2267,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2268,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2268,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2269,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2269,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2269,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2269,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2270,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2271,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2272,1,BK polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2273,1,B-cell prolymphocytic leukaemia,B-cell small lymphocytic lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2273,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2274,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
2275,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
2275,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2276,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2277,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2278,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2278,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2279,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2280,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2280,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2280,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2280,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2280,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2280,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2280,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2280,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2281,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2281,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2281,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2282,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2282,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2282,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2283,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
2283,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2283,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2284,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2284,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2284,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2284,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2284,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2284,6,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2284,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2285,1,Administration site paraesthesia,Administration site reactions NEC,Administration site reactions,Genrl,N
2286,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2286,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2286,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2286,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2286,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2286,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2287,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2287,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2287,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2288,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
2289,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2289,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2289,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2290,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2291,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2291,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2291,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2291,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2292,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2293,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2294,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2294,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2294,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2295,1,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2296,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2296,2,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
2296,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2296,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2296,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2296,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2296,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2296,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2297,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2298,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2299,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2299,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2300,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2300,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2300,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2300,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2301,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2302,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
2303,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2303,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2303,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2303,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2304,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2304,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2304,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2305,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2306,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2306,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2307,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2307,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2308,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2309,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2309,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2309,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2309,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
2310,1,Glioblastoma multiforme,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
2310,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2310,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2311,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2311,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2312,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2312,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2313,1,Nodular melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2314,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2314,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2315,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2315,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2315,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2315,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2315,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2316,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2316,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2317,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2317,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
2317,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2317,4,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2317,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2317,6,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
2318,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2318,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2318,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2318,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2319,1,Protein-losing gastroenteropathy,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2320,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2320,2,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2320,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2320,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2320,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2320,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2321,1,Bronchial hyperreactivity,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2321,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2322,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2322,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2322,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2322,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2322,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2322,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2323,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
2323,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2323,3,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2323,4,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2324,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2324,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2325,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2325,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2326,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2327,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2327,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2327,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2328,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2328,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2329,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2330,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2330,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2330,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2330,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2330,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2330,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2331,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2331,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2331,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2331,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2332,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2332,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2332,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2332,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2332,5,Serum sickness-like reaction,Allergic conditions NEC,Allergic conditions,Immun,N
2333,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2334,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2334,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2334,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2335,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2335,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2336,1,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2337,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2338,1,Gallbladder rupture,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
2338,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2338,3,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2338,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2338,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2339,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2339,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2339,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2339,4,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2339,5,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2340,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2341,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2341,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2342,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2343,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2343,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2344,1,Headache,Headaches NEC,Headaches,Nerv,N
2344,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2345,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2346,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2346,2,Headache,Headaches NEC,Headaches,Nerv,N
2346,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2347,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2347,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2347,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2347,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2347,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2348,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2349,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2349,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2350,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,Y
2351,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2351,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2351,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2351,4,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2351,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2352,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2353,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2354,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2354,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2354,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2354,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2354,5,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2354,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2354,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2354,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2355,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2355,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2355,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2355,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2355,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2355,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2355,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2356,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2357,1,Ocular lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
2357,2,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2358,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2358,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2358,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2358,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
2359,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2359,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2359,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2360,1,B-cell lymphoma stage IV,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
2360,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2360,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2360,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2361,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2362,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2362,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2362,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2362,4,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2363,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2363,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2363,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2364,1,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
2365,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2365,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2366,1,Gastroenteritis salmonella,Salmonella infections,Bacterial infectious disorders,Infec,N
2366,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2367,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2368,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2369,1,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
2369,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2369,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2369,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2370,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2370,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2371,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2371,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2372,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2373,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2373,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2373,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2373,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2374,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2374,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2375,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2375,2,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2376,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2377,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2377,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2378,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2378,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2378,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2379,1,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
2380,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2380,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2380,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2380,4,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2380,5,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2380,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2381,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2382,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2382,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2382,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2382,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2383,1,Headache,Headaches NEC,Headaches,Nerv,N
2383,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2383,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2383,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2384,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2384,2,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2384,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2385,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2385,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2385,3,Systemic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2386,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2386,2,Ureteric stenosis,Ureteric disorders NEC,Ureteric disorders,Renal,N
2386,3,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2387,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2387,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2387,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2387,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2387,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2387,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2387,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2387,8,Scleroderma renal crisis,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2387,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2388,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2388,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2389,1,Cerebellar haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2389,2,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2389,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2389,4,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
2389,5,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2389,6,Pituitary haemorrhage,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
2389,7,Pituitary infarction,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
2389,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2390,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2390,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2390,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2391,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2391,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2392,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2393,1,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
2393,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2393,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2393,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2393,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2393,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2393,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2394,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2394,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2394,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2394,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2395,1,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2395,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2395,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2395,4,Pituitary infarction,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
2395,5,Retinal infarction,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2396,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2396,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2397,1,Cerebellar haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2397,2,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2397,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2397,4,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
2397,5,Pituitary haemorrhage,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
2397,6,Pituitary infarction,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
2398,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2399,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2399,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2400,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2401,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2402,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2402,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2402,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2402,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2402,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2402,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2402,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2403,1,Peripheral T-cell lymphoma unspecified,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
2403,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2404,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2404,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
2404,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2404,4,Headache,Headaches NEC,Headaches,Nerv,N
2404,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2404,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2404,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2404,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2404,9,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2405,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2406,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2406,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2406,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2406,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2406,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2406,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2406,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2407,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2407,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2407,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2407,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2407,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2407,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2407,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2408,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2408,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2408,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2409,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2410,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2411,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2411,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2411,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2412,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2412,2,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
2413,1,Cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
2413,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2414,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2415,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2415,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2415,3,Dysdiadochokinesis,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2415,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
2415,5,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
2415,6,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2415,7,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2415,8,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2415,9,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
2415,10,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2415,11,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2415,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2415,13,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2416,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2416,2,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
2417,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2417,2,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
2418,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2418,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2418,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2418,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2419,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2419,2,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
2420,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2420,2,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
2421,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2421,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2422,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2422,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2422,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2422,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2422,5,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2422,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2423,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2423,2,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
2424,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2424,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2424,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2425,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2425,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2425,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
2426,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2426,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2427,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2427,2,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
2428,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2429,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2430,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2430,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2431,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2431,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2431,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2431,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2431,5,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
2432,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2432,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2432,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2433,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2433,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2433,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2433,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
2434,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2434,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2434,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2434,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
2434,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
2435,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
2436,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2436,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2437,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2437,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2438,1,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
2438,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2438,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2438,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2439,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
2439,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2439,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2440,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2440,2,Headache,Headaches NEC,Headaches,Nerv,N
2441,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2441,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2441,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2442,1,Acute biphenotypic leukaemia,Leukaemias acute NEC,Leukaemias,Neopl,N
2442,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2442,3,Blast cells present,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
2442,4,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
2442,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2442,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2442,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2442,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2442,9,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2442,10,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2442,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2443,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2443,2,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2443,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2444,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2444,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2444,3,Device leakage,Device issues NEC,Device issues,Prod,N
2444,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2444,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2444,6,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2444,7,Suprapubic pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2445,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2445,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2445,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2446,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2446,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2446,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2446,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2447,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2447,2,Headache,Headaches NEC,Headaches,Nerv,N
2447,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2447,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2448,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2448,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
2448,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2448,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2449,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
2450,1,Chronic lymphocytic leukaemia recurrent,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
2450,2,Pneumonia cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,N
2451,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2451,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2451,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2451,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2451,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2451,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2452,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2452,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
2453,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2453,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2454,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2454,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2455,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
2456,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2456,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2456,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2456,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2457,1,Ear pruritus,Ear disorders NEC,Aural disorders NEC,Ear,N
2457,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2457,3,Tongue pruritus,Tongue signs and symptoms,Tongue conditions,Gastr,N
2458,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2459,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2459,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2459,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2460,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2460,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2461,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2461,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2461,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2461,4,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
2461,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2462,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
2463,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2463,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2463,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2463,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2464,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2464,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2464,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2464,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2464,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2465,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2465,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2466,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,Y
2467,1,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
2468,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2469,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2469,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2469,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2469,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2470,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2470,2,Bone marrow infiltration,Haematological disorders,Haematological disorders NEC,Blood,N
2470,3,Hairy cell leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
2470,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2470,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2470,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2471,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2471,2,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2471,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2471,4,Lung neoplasm,Respiratory tract and pleural neoplasms malignancy unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2471,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2471,6,Small intestinal resection,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
2472,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
2472,2,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2472,3,Vulvovaginal ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2473,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2473,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2474,1,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2474,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2474,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2474,4,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
2474,5,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2475,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
2476,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2477,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2477,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2477,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2478,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
2478,2,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
2478,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2479,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2479,2,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
2479,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2480,1,Brain hypoxia,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,Y
2480,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2480,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2481,1,Human polyomavirus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2481,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2481,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2481,4,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2482,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2482,2,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2482,3,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
2482,4,Quadrantanopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
2482,5,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2483,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
2483,2,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2483,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2483,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2484,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
2484,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2484,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2484,4,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2484,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2484,6,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2484,7,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2485,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2486,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2486,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2486,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2487,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2487,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2487,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2487,4,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2487,5,Myopathy,Myopathies,Muscle disorders,Musc,N
2487,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2487,7,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2488,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2489,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2489,2,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
2490,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2490,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2490,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2490,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
2490,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2490,6,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2490,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2490,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2490,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2490,10,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
2491,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
2491,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2491,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2492,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2492,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2492,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2492,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2492,5,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2492,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2493,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2493,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2493,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2494,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2494,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2495,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2495,2,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
2496,1,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
2496,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2496,3,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2496,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2497,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2497,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2497,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2498,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
2499,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
2499,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2500,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
2501,1,Hepatitis B virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2502,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2503,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2503,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2504,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
2504,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2504,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2504,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2504,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
2505,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
2505,2,Immunodeficiency common variable,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
2506,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2507,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
2507,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
2508,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
2508,2,Immunodeficiency common variable,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
2509,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2510,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2510,2,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2510,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2510,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2510,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2510,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2510,7,Proteus infection,Proteus infections,Bacterial infectious disorders,Infec,N
2510,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2510,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2510,10,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2510,11,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2510,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2510,13,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2511,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
2511,2,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2511,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2512,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2513,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2513,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2513,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2514,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
2514,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2514,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2514,4,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
2514,5,Placenta praevia,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
2514,6,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2514,7,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
2515,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2516,1,Granuloma skin,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
2516,2,Immunodeficiency common variable,Primary immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
2517,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2517,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2517,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2517,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2518,1,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,Y
2518,2,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
2519,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2519,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2519,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2519,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2520,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
2521,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2522,1,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
2522,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2523,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2524,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2524,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2524,3,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2525,1,Lymphatic disorder,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2526,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2526,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2526,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2526,4,Hand-eye coordination impaired,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2526,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2527,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2527,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2527,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2527,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2527,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2528,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2528,2,Myopericarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
2528,3,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2529,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2529,2,Immunoglobulin G4 related disease,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2529,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2529,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2530,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2530,2,Immunoglobulin G4 related disease,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2530,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2531,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2531,2,Immunoglobulin G4 related disease,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2531,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2531,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2532,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2532,2,Immunoglobulin G4 related disease,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2532,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2532,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2532,5,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
2532,6,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
2533,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2533,2,Immunoglobulin G4 related disease,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2533,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2533,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2534,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2534,2,Learning disorder,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
2534,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2535,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2535,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2536,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2536,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2537,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2538,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2539,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2539,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2539,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2539,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
2539,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2539,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2540,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2540,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2541,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2541,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2542,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2543,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2543,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2543,3,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2544,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2544,2,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2544,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2545,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
2545,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2545,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2545,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2545,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2546,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2547,1,B-cell small lymphocytic lymphoma,B-cell small lymphocytic lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2547,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2547,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2547,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2547,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2547,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2547,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2547,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2547,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2548,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2549,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2549,2,Migraine,Migraine headaches,Headaches,Nerv,N
2549,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2549,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2550,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2550,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2550,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2551,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2552,1,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2552,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2552,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2552,4,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
2552,5,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2553,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2553,2,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2553,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2553,4,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2553,5,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2553,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2553,7,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
2553,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2553,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2553,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2553,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2554,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
2555,1,Anterior interosseous syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
2555,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2555,3,Type III immune complex mediated reaction,Allergic conditions NEC,Allergic conditions,Immun,N
2556,1,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2556,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2556,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2556,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2556,5,Stoma site reaction,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
2557,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2557,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2557,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2557,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2558,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2558,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2558,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2558,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2558,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2558,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2559,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2560,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2561,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2561,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2561,3,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2561,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
2561,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2561,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2561,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2561,8,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2562,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2562,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2562,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2562,4,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
2562,5,Ileal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2562,6,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2562,7,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
2563,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2564,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2564,2,Genital neoplasm malignant female,Female reproductive neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
2564,3,Haemophilus infection,Haemophilus infections,Bacterial infectious disorders,Infec,N
2564,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2564,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2565,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
2566,1,Central nervous system lupus,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2566,2,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
2566,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2566,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2566,5,Meningitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
2566,6,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
2567,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2567,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2568,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2569,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2569,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2569,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2570,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2571,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2572,1,Headache,Headaches NEC,Headaches,Nerv,N
2573,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2574,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2574,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2574,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2574,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2575,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2575,2,Laryngeal inflammation,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2575,3,Mucosal hypertrophy,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2575,4,Vocal cord inflammation,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2575,5,Vocal cord thickening,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2576,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2576,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2576,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2576,4,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2576,5,Headache,Headaches NEC,Headaches,Nerv,N
2576,6,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
2576,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
2576,8,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2576,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2576,10,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2577,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2577,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2578,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2579,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2579,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2579,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2579,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2580,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2580,2,Pulmonary function test abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
2580,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2581,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2581,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2581,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2581,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2581,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2581,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2581,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2582,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2582,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2582,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2583,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2583,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2583,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2584,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2585,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2586,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2586,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2587,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2587,2,Pulmonary function test abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
2587,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2588,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2588,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2588,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2588,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2588,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2588,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2589,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2589,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2589,3,Headache,Headaches NEC,Headaches,Nerv,N
2589,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2590,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2590,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
2590,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2590,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2591,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2592,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2592,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2592,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2592,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2592,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2593,1,Chronic lymphocytic leukaemia recurrent,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
2594,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2595,1,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2596,1,B-cell lymphoma recurrent,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
2597,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2597,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2598,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2598,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2598,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2599,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2599,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2600,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2600,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2600,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2600,4,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
2600,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2601,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2601,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2601,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2602,1,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2602,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2602,3,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
2602,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2602,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2602,6,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2602,7,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2603,1,Chest wall tumour,Soft tissue neoplasms malignant and unspecified NEC (excl sarcomas),Soft tissue neoplasms malignant and unspecified,Neopl,N
2603,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
2603,3,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2603,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2603,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2604,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2604,2,Beta 2 microglobulin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2604,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2604,4,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2604,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2605,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2605,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2605,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2605,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2606,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
2606,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2606,3,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,Y
2607,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2607,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2607,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2608,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2608,2,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
2608,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2608,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2608,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2608,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2609,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2609,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2609,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2609,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2609,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2609,6,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2609,7,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2610,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2611,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
2611,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2611,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2612,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2613,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2613,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2613,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2613,4,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2614,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2615,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2615,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2615,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2615,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2615,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2615,6,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2615,7,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
2615,8,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2615,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2615,10,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
2615,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2615,12,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2616,1,Allergic cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2616,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2616,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2616,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2617,1,Ear pruritus,Ear disorders NEC,Aural disorders NEC,Ear,N
2617,2,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2617,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2617,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2617,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2618,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2618,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2618,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2619,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
2619,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2620,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2621,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2622,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2623,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2624,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2625,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2626,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2626,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2627,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
2627,2,Metastases to chest wall,Metastases to specified sites,Metastases,Neopl,N
2627,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
2627,4,Necrotic lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2627,5,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2627,6,Renal mass,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2628,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2628,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2628,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2628,4,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2628,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2628,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2629,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2630,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
2630,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2631,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2631,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2631,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2632,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2632,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2632,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2632,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2632,5,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2632,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2633,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2633,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
2634,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2635,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2635,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
2636,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2637,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2637,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2637,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2638,1,Chronic lymphocytic leukaemia recurrent,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
2639,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2640,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2640,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2641,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2641,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2642,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2643,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2643,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2643,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2643,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2643,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2643,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2643,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2644,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2645,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2646,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2646,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2647,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2647,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2647,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2647,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2648,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2648,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2649,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2649,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2650,1,B-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2650,2,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,Y
2651,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2651,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2652,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2653,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2653,2,Malignant neoplasm of ampulla of Vater,Hepatobiliary neoplasms malignant NEC,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
2653,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2654,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2655,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2655,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2655,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2655,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2655,5,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2655,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2655,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2656,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2657,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2658,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2659,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2660,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2660,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2661,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2662,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2663,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2663,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2664,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2664,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2664,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2664,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2665,1,Granulomatous lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2665,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
2665,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2665,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
2665,5,Primary mediastinal large B-cell lymphoma,Primary mediastinal large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2665,6,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
2665,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2666,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2666,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2666,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2666,4,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2666,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2666,6,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
2666,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2666,8,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2667,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2668,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2669,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2669,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2669,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2669,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2669,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2669,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2670,1,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
2671,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2671,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2672,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2672,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2673,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2673,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2673,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2673,4,Waldenstrom's macroglobulinaemia,Waldenstrom's macroglobulinaemias,Lymphomas non-Hodgkin's B-cell,Neopl,Y
2674,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2674,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2674,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2674,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2674,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2675,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2675,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
2676,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2677,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2677,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2677,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2677,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2677,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2677,6,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
2678,1,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2678,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
2678,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2678,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2678,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2679,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2680,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
2680,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2681,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2681,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2681,3,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
2681,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
2681,5,Microvillous inclusion disease,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
2681,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2682,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2683,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2683,2,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2683,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2683,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2683,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2683,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
2683,7,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2684,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2684,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2684,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2684,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2684,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2685,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2686,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2686,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2687,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2687,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2687,3,Disability,Disability issues,Lifestyle issues,SocCi,N
2687,4,Neuromyelitis optica spectrum disorder,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
2688,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2688,2,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
2689,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2689,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2689,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2690,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2690,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2690,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2691,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2691,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2691,3,Squamous cell carcinoma of head and neck,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2692,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2692,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2692,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2693,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2693,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2693,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2694,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2695,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2696,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2696,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2697,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2698,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2698,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2699,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2699,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2700,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2701,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2702,1,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2703,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2703,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2703,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2703,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2704,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2704,2,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2704,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2704,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2704,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2704,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2705,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2706,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2706,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
2707,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2707,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2707,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2707,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2707,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2707,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2707,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2708,1,Hyperammonaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,Y
2709,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2709,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2709,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2709,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2709,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2709,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2709,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2709,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2709,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2709,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2710,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2710,2,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2710,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2710,4,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2710,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2710,6,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2710,7,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2710,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2710,9,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2710,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2711,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2711,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2711,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2711,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2711,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2711,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2711,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2712,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2712,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2712,3,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
2712,4,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2712,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2713,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2714,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2714,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2714,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2715,1,Headache,Headaches NEC,Headaches,Nerv,N
2715,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2715,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2715,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2716,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2716,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2716,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2716,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
2717,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2718,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2718,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2719,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2719,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2719,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2720,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2720,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2720,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2720,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2721,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2721,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2721,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2721,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2722,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2722,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2722,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2723,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2723,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2723,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2724,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2724,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2724,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2724,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2725,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2725,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2726,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2726,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2726,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2727,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2728,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2728,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2729,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2729,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2730,1,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
2731,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2731,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2731,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2731,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2731,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2731,6,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2731,7,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2732,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2732,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2732,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2732,4,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
2732,5,Short stature,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2733,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,Y
2734,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2734,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2734,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2735,1,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2736,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2736,2,Retinitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2736,3,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
2737,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2738,1,Necrotising retinitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
2739,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2739,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2739,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2740,1,Osteomyelitis acute,Bone and joint infections,Infections - pathogen unspecified,Infec,N
2741,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2741,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2741,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2742,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2742,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2743,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2743,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2743,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2743,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2743,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2743,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2744,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2745,1,Eosinophilic granulomatosis with polyangiitis,Vasculitides,Immune disorders NEC,Immun,N
2745,2,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
2745,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2745,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2745,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2745,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2746,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2746,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2746,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2746,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2747,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2747,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2748,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2748,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2749,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2749,2,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2749,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2749,4,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2750,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2750,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2750,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2750,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2751,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2751,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2751,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2752,1,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2752,2,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
2753,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2753,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2753,3,Viral sepsis,Viral infections NEC,Viral infectious disorders,Infec,N
2754,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2755,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2755,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2755,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2756,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2757,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2758,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2758,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
2758,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2758,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2758,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2758,6,Rebound psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2758,7,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
2758,8,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
2758,9,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2759,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2760,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2761,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2762,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,Y
2762,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2763,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2764,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2765,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2766,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2767,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2768,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2769,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2770,1,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2771,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2772,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2772,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2772,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2773,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2774,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2774,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2775,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2775,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2775,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2775,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2775,5,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
2776,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2776,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2776,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2776,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2777,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2777,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2777,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2777,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2778,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2778,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2779,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2779,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2779,3,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2779,4,Stenotrophomonas sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2779,5,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2780,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2780,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2781,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2781,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2782,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2782,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2783,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2783,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
2784,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2784,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2785,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2785,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
2786,1,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2786,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2787,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2787,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2788,1,Headache,Headaches NEC,Headaches,Nerv,N
2789,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2790,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2790,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2791,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2792,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2792,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2793,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2793,2,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2793,3,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2793,4,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2793,5,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2793,6,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2793,7,Humerus fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2793,8,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2793,9,Nephrocalcinosis,Renal lithiasis,Urolithiases,Renal,N
2793,10,Pathological fracture,Fractures NEC,Fractures,Musc,N
2793,11,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2793,12,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2794,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
2795,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2795,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2795,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2795,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2795,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2795,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2795,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2796,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
2796,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
2796,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
2796,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
2797,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2797,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2797,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2797,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2798,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
2798,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
2798,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
2798,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
2799,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2800,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2801,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2801,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2802,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2802,2,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2802,3,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
2802,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2802,5,Quadrantanopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
2802,6,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2803,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2803,2,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2804,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2804,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2804,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2805,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
2806,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2806,2,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2806,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2806,4,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2806,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2806,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2806,7,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
2806,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2806,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2806,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2806,11,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2806,12,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
2806,13,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2807,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2807,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
2808,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2808,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2808,3,Squamous cell carcinoma of head and neck,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2809,1,Eosinophilic fasciitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2810,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2810,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2810,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2811,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2811,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2812,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2812,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2813,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2814,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2815,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2816,1,Abdominal lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2816,2,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
2817,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2817,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2817,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2818,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2819,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2819,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2820,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2821,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2822,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2823,1,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2824,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2824,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2825,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2826,1,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
2827,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2828,1,Eosinophilic fasciitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
2829,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2830,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2831,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2831,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2832,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2833,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2834,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
2835,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2836,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2836,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2836,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2837,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2838,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2839,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2840,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2841,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2842,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2843,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2844,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2845,1,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2846,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2847,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2847,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2847,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2847,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2848,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2849,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2849,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2849,3,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
2850,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2850,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2851,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2852,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2852,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2853,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
2854,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
2854,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2855,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
2855,2,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
2855,3,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
2855,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
2856,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2857,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2858,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2859,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2860,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2860,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2860,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2860,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2860,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2860,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2860,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
2860,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2860,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2860,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2861,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2861,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2862,1,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
2863,1,Ejection fraction abnormal,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2863,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2863,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2864,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2864,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2864,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2865,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2865,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2865,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2865,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2865,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2865,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2865,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2865,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2865,9,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2866,1,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
2866,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2867,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2867,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2868,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2868,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2868,3,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2868,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2868,5,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2868,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2868,7,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2868,8,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
2868,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2869,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2869,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2869,3,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2869,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2869,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2869,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2870,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2870,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2870,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2871,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2871,2,Headache,Headaches NEC,Headaches,Nerv,N
2871,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2871,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2871,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2872,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2872,2,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
2872,3,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2872,4,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2873,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2873,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2873,3,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
2873,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2873,5,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2873,6,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2874,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2875,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2876,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2876,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2877,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2877,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2878,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2878,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2879,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2879,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2880,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2880,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2881,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2881,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2882,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2883,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2883,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2884,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2884,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2885,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2885,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2886,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2886,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2887,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2887,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2888,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2888,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2889,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2889,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2890,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2890,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2891,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2892,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2893,1,Borrelia infection,Borrelial infections,Bacterial infectious disorders,Infec,N
2894,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2895,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2896,1,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
2897,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2897,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2898,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2898,2,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2899,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2899,2,Necrotising retinitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
2899,3,Retinitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2899,4,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
2900,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2900,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2901,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2901,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2902,1,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
2903,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2903,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2904,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2904,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2905,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2905,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2906,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2907,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2908,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2909,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2910,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2911,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2912,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2913,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2914,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2915,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2916,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2917,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2918,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2919,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2920,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2921,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2922,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2923,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2924,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2925,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2926,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2927,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2928,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2929,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2930,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2931,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2932,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2933,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2934,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2935,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2936,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2937,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2938,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2939,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2940,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2941,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2942,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2943,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2944,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2945,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2946,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2947,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2948,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2949,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2950,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2951,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2952,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2953,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2954,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2955,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2956,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2957,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2958,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2959,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2960,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2961,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2962,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2963,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2964,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2965,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2966,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2967,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2968,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2969,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2970,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2971,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2972,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2973,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2974,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2975,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2976,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2977,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2978,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2979,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2980,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2981,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2982,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2983,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2984,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2985,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2986,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2987,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2988,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2989,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2990,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2991,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2992,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2993,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2994,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2995,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
2996,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2997,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2998,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2999,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3000,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
3001,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
3002,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
3003,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3004,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3005,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3006,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3007,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3008,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3009,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3010,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3011,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3012,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3013,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3014,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3015,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3016,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3017,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3018,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3019,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3020,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3021,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3022,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3023,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3024,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3025,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3026,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3027,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3028,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3029,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3030,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3031,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3032,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3033,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3034,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3035,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3036,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3037,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3038,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3039,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3040,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3041,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3042,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3043,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3044,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3045,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3045,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3045,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3045,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3045,5,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
3045,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3046,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3047,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3048,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3049,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3050,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3051,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3052,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3053,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3054,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
3055,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3056,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
3057,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
3058,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
3059,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3060,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3061,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3062,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3063,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3064,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3065,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3066,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3067,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3068,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3069,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3070,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3071,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3072,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3073,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3074,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3075,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3076,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3077,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3078,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3079,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3080,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3081,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3082,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3083,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3084,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3085,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3086,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3087,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3088,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3089,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3090,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3091,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3092,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3093,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3094,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3095,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3096,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3097,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3098,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3098,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3099,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3099,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3099,3,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3099,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3099,5,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3100,1,Extramedullary haemopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
3100,2,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
3101,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3101,2,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
3102,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3102,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3102,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3102,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3102,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3103,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3103,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
3104,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3104,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3105,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3105,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3105,3,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3105,4,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
3105,5,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3105,6,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3106,1,Angiodysplasia,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
3106,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3106,3,Pre-existing condition improved,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3106,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3107,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
3107,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3107,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3108,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
3109,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
3109,2,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
3110,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3111,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3112,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3112,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3113,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
3114,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3114,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3114,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3114,4,Placenta accreta,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
3114,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3115,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3115,2,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
3115,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3115,4,Positive airway pressure therapy,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
3115,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3116,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3116,2,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
3116,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
3117,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3118,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3119,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
3119,2,Exposure to SARS-CoV-2,Exposures to agents or circumstances NEC,"Exposures, chemical injuries and poisoning",Inj&P,N
3120,1,Citrobacter bacteraemia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3121,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3122,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3122,2,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
3123,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3123,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3124,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3125,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3125,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3126,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3126,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3126,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3127,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3127,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3127,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3127,4,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
3127,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3127,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3128,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3128,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3128,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3128,4,Heart failure with reduced ejection fraction,Left ventricular failures,Heart failures,Card,N
3129,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3130,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3131,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3132,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3132,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3132,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3133,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,Y
3134,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3134,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3134,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3134,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3135,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3135,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3135,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3136,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3136,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3136,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3137,1,Henoch-Schonlein purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
3138,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3138,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3138,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3139,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3139,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
3139,3,Congestive hepatopathy,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
3139,4,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3139,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
3139,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
3140,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
3141,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3141,2,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3141,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3141,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3142,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3142,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3142,3,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
3142,4,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3142,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3143,1,Blast cell count increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
3143,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3143,3,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3143,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3143,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3143,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3143,7,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
3143,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3143,9,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3143,10,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3143,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3144,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3145,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3145,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3145,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
3146,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3147,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3148,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
3149,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
3150,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3150,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3150,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
3150,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3150,5,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3150,6,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
3150,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3150,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3150,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3150,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3150,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
3150,12,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
3150,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3150,14,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3151,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3151,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3152,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
3152,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3152,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3153,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3153,2,Headache,Headaches NEC,Headaches,Nerv,N
3153,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3154,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3155,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
3155,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3155,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3155,4,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3156,1,Headache,Headaches NEC,Headaches,Nerv,N
3157,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3158,1,Lower gastrointestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3159,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
3160,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3160,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3161,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3162,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3162,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3162,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3163,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3164,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3164,2,Necrotic lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3165,1,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
3166,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3166,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3167,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3168,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3168,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3169,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3170,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3171,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3172,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3173,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3173,2,Infection reactivation,Infections NEC,Infections - pathogen unspecified,Infec,N
3174,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3174,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3174,3,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3174,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3175,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3176,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
3177,1,AST/ALT ratio abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3177,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
3178,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3178,2,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
3178,3,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3179,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
3180,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3180,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3180,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3181,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
3181,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3181,3,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
3181,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3181,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3181,6,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3181,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3181,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3182,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
3183,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3183,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3184,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
3184,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
3184,3,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
3184,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3184,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3184,6,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
3184,7,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
3185,1,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3186,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3186,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3187,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3187,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3187,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3187,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3187,5,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3188,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
3188,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
3189,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
3189,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
3190,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3191,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3192,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3193,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3193,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3193,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
3193,4,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3194,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3195,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3195,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3195,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3195,4,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3195,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3195,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3196,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3196,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3197,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3197,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3198,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3199,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3199,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3199,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3200,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3201,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
3201,2,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
3202,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3202,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3203,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3203,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3203,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3203,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3203,5,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3203,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3203,7,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3204,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3204,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3205,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3206,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3206,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3207,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3207,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
3207,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3208,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
3208,2,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
3209,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
3209,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3210,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3211,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3212,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
3212,2,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
3213,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3214,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3214,2,Procedural vomiting,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3215,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3215,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3215,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3216,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
3217,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3218,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3219,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3220,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3221,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3222,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
3222,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3223,1,Diabetic nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
3223,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3223,3,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3224,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3224,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3224,3,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
3224,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3224,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
3225,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3225,2,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
3226,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3226,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3227,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3228,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3229,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
3229,2,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
3229,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
3230,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
3231,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3231,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3231,3,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
3231,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3231,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3231,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3232,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3232,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
3232,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3233,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3233,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3234,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3235,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3235,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3235,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3235,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3235,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
3235,6,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3235,7,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3235,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3236,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3237,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3237,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
3238,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3238,2,Migraine,Migraine headaches,Headaches,Nerv,N
3238,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
3238,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3239,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3240,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
3241,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
3241,2,Headache,Headaches NEC,Headaches,Nerv,N
3241,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3242,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
3243,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3243,2,Glomerulonephritis rapidly progressive,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3243,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3243,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3243,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3243,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3243,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3244,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
3245,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
3245,2,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
3246,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3247,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
3247,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3247,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
3248,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3248,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3249,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3250,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3250,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
3250,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
3251,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3251,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3251,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3252,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3253,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3254,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3254,2,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
3254,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3254,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3255,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3256,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3257,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3258,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3258,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3258,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3259,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
3259,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
3259,3,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3260,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
3261,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3261,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3262,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3262,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3263,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3264,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3265,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
3266,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3266,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3266,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3266,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3266,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3266,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3266,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
3266,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3266,9,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3267,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3267,2,Vaginal cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3268,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3268,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
3268,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3268,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3268,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3269,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3269,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3269,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3269,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3269,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3270,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
3270,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3270,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3270,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3270,5,Pulmonary function test abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
3270,6,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
3271,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3271,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
3271,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3271,4,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
3271,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3272,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3272,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3273,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3273,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3274,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3274,2,Pulmonary function test abnormal,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
3274,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
3275,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3276,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3276,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3276,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3277,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3277,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3277,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3278,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3278,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3278,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3278,4,Headache,Headaches NEC,Headaches,Nerv,N
3278,5,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
3278,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3278,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3278,8,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3278,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3279,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3280,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3280,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3281,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3281,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3281,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
3282,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3283,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3284,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3284,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3284,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3284,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3285,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3286,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3287,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3287,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3287,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3288,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3289,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3289,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3290,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
3290,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3290,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3290,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3291,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
3291,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
3292,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3293,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
3294,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3294,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3294,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3295,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3295,2,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
3295,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3296,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3296,2,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3296,3,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3296,4,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3296,5,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3296,6,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3296,7,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3296,8,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
3296,9,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
3296,10,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3296,11,Death,Death and sudden death,Fatal outcomes,Genrl,N
3296,12,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3296,13,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3296,14,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3296,15,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3296,16,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3296,17,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3296,18,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3296,19,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3296,20,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
3296,21,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3296,22,Headache,Headaches NEC,Headaches,Nerv,N
3296,23,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
3296,24,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3296,25,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3296,26,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3296,27,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
3296,28,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
3296,29,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3296,30,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3296,31,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
3296,32,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3296,33,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3296,34,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3296,35,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3296,36,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3296,37,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3297,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3297,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3298,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3299,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,Y
3299,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
3299,3,Therapeutic drug monitoring analysis not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3300,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3301,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3302,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
3303,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3303,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3304,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
3305,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
3306,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
3307,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3307,2,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
3307,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
3308,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3308,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3308,3,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3309,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
3310,1,Vulvitis,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
3311,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3312,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3313,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
3314,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3314,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3314,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3314,4,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3314,5,Headache,Headaches NEC,Headaches,Nerv,N
3314,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3314,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3314,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3314,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3315,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3315,2,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
3315,3,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3315,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3315,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
3315,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3316,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
3316,2,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
3316,3,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3316,4,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
3316,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
3317,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
3318,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
3318,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3319,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
3319,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3319,3,Vaccination failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3320,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3320,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3320,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3320,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3321,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3321,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3321,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3321,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3321,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
3321,6,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3321,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3321,8,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3322,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3323,1,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3323,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
3323,3,Phospholipase A2 activity increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
3324,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3324,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3324,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3324,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3324,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
3324,6,Pulmonary congestion,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3324,7,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3324,8,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3325,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3325,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3325,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3325,4,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3325,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3325,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3325,7,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3325,8,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
3325,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3325,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3326,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3327,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3327,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3327,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3328,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3329,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3330,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3330,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3330,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3331,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3331,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3332,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3332,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3333,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3333,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
3333,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3333,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3333,5,Vaccination failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3334,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3334,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3334,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3335,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3335,2,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,Y
3335,3,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3335,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3335,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3335,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3335,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3335,8,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3335,9,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3335,10,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3335,11,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
3335,12,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
3335,13,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3335,14,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
3335,15,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3335,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3336,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3337,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3337,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3338,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3338,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3338,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3338,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
3338,5,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3338,6,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
3339,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3340,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3341,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3342,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
3343,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3344,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
3345,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
3346,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
3347,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3347,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3348,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3348,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3348,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3349,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3349,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3349,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
3349,4,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3349,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3349,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3349,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3349,8,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3350,1,Neuritis,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3350,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3351,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3351,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3351,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3352,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3352,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3353,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
3354,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3354,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3355,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3356,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3356,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3357,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3357,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3357,3,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3358,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3359,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3360,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3360,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3360,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3360,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3360,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3361,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
3362,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
3363,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3364,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3364,2,Vaginal cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3365,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3366,1,Drug specific antibody,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
3366,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3366,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3367,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3368,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3368,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3368,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
3368,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3368,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3368,6,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
3369,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3370,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
3371,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
3371,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3371,3,Vaccination failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3372,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3372,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3373,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3373,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3373,3,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3373,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3374,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3375,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3375,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3375,3,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
3376,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3376,2,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
3376,3,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
3376,4,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3376,5,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
3376,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3376,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3376,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3377,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3377,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3377,3,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
3378,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3379,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3380,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
3381,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
3381,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3381,3,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3382,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3382,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
3382,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3382,4,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3382,5,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
3382,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3383,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3383,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3384,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
3385,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
3386,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3386,2,Vaginal cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3387,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3388,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
3389,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3390,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3390,2,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3391,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
3392,1,Capillary nail refill test,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3392,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3392,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3392,4,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3393,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3393,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3393,3,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3394,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3395,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3396,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3396,2,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3397,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
3398,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3398,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3398,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3399,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3399,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3399,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3399,4,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3400,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3400,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3400,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
3400,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3400,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3401,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3402,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3402,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3403,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3404,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
3404,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3405,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3405,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3406,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3406,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3406,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3407,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3408,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3408,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3408,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3408,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3409,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3409,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3410,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3411,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3412,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3413,1,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
3414,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3414,2,Product temperature excursion issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3415,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3415,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3416,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
3417,1,Administration site reaction,Administration site reactions NEC,Administration site reactions,Genrl,N
3417,2,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
3417,3,Breast disorder,Breast disorders NEC,Breast disorders,Repro,N
3417,4,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3417,5,Connective tissue disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
3417,6,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3417,7,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3417,8,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
3417,9,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
3417,10,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3417,11,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3417,12,Hepatobiliary disease,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
3417,13,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3417,14,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3417,15,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
3417,16,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3417,17,Investigation,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
3417,18,Mediastinal disorder,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
3417,19,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
3417,20,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
3417,21,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
3417,22,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
3417,23,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3417,24,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3417,25,Procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3417,26,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
3417,27,Reproductive tract disorder,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
3417,28,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
3417,29,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3417,30,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
3418,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3418,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3419,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3419,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3420,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3421,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3422,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3423,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3423,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3423,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
3423,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3423,5,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3423,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3423,7,Discoloured vomit,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3423,8,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,Y
3423,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3423,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3423,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3424,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
3424,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
3424,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
3424,4,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
3424,5,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
3424,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3424,7,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
3425,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3425,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3426,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3426,2,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
3426,3,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3426,4,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3427,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
3427,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3428,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3428,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3428,3,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
3429,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3430,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3430,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3430,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3431,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3431,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
3431,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3432,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3433,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3434,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3434,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3435,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
3435,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3435,3,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
3436,1,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3436,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3436,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3436,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3436,5,Stoma site reaction,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
3437,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3437,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3437,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3438,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3438,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3439,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
3439,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3439,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3439,4,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
3439,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3440,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3441,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3441,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3441,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3441,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
3442,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3442,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3442,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
3443,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3444,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3445,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3445,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3445,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3445,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3445,5,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3446,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3446,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3446,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
3446,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
3446,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3447,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3448,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3448,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
3448,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3449,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3450,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3450,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3451,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3451,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3452,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3453,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3453,2,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
3454,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
3455,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3456,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3456,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3456,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3456,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3456,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3457,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3457,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
3458,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3459,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3460,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3460,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3461,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3462,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3462,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
3463,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3464,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3465,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3465,2,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
3465,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3466,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
3467,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3467,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3468,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
3469,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3469,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3469,3,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
3469,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3469,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3470,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3470,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3471,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3471,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3472,1,Necrotising soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
3472,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3473,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3473,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3474,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
3475,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3475,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3476,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3476,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3476,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3477,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3477,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3477,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3477,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3477,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3477,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3477,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3478,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3478,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3478,3,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
3479,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3480,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
3480,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3480,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3480,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3481,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
3481,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3481,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3482,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3483,1,Pancreatic cyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
3484,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3484,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3485,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
3486,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3486,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3487,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3487,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3488,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3488,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3488,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3488,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3489,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3489,2,Intravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
3489,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3489,4,Warm autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
3490,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3491,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3492,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3493,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3493,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3493,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3493,4,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
3494,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3494,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
3494,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
3494,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3495,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
3495,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3495,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3496,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3497,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3498,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3498,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3499,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
3499,2,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
3500,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3501,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3501,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3502,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3503,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
3503,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3503,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3504,1,Autoimmune thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
3504,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3505,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3505,2,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
3505,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3506,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3507,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3508,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
3509,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
3509,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3510,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3510,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3511,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3511,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
3512,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3512,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3512,3,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3512,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3513,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3513,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3514,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3515,1,Neuromyelitis optica spectrum disorder,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
3515,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3516,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3516,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3517,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3518,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3519,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3519,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3519,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3519,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3519,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3519,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3519,7,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3519,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3519,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3519,10,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
3519,11,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
3519,12,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3519,13,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3520,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3520,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3520,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3521,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
3521,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3521,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3522,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
3522,2,Secondary immunodeficiency,Acquired immunodeficiency syndromes,Immunodeficiency syndromes,Immun,N
3522,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3523,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
3523,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3524,1,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
3524,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3524,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3525,1,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
3525,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3525,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3525,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
3526,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3526,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3526,3,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
3526,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
3526,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3527,1,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
3527,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3527,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3527,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
3527,5,Spontaneous rupture of membranes,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
3528,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3528,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3529,1,Genital infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3529,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
3529,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
3529,4,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3529,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3529,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
3529,7,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3529,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
3529,9,Vulval abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
3530,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3531,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3531,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3531,3,Headache,Headaches NEC,Headaches,Nerv,N
3532,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3533,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
3533,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3534,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3534,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3535,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3536,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
3537,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3537,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
3538,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
3538,2,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
3538,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3538,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
3539,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3540,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3540,2,Headache,Headaches NEC,Headaches,Nerv,N
3540,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3540,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3541,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3542,1,Heart rate,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3543,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3543,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3544,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3545,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3546,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3547,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3548,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3548,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3548,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3549,1,Herpes simplex encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
3550,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3550,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3551,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3551,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3552,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3552,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3553,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3554,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3554,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
3554,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3555,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3555,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3556,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3557,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3558,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3559,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3560,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3560,2,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
3560,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
3561,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3562,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3563,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3563,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3563,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3564,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3564,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3565,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3566,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
3567,1,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
3568,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
3569,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3570,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3571,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
3571,2,Heart failure with preserved ejection fraction,Left ventricular failures,Heart failures,Card,N
3571,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3571,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
3571,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3572,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3572,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3572,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3573,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
3573,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3574,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
3574,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3574,3,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
3574,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
3575,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3575,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3576,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3576,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
3577,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
3578,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3579,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3580,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3580,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3580,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3580,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3580,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3581,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3582,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3583,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
3584,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3584,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3585,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3585,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
3585,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3586,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3586,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3587,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3588,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
3589,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3590,1,Complement factor decreased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
3590,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3590,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3590,4,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
3591,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3592,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3593,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3594,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3595,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3596,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3596,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3597,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3598,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3598,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3599,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3600,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3601,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3601,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
3601,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3601,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3602,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3603,1,Culture urine positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
3603,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
3603,3,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
3603,4,Physical disability,Disability issues,Lifestyle issues,SocCi,N
3603,5,Rehabilitation therapy,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
3603,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3603,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3603,8,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
3604,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3605,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
3606,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3607,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3608,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3608,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
3609,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3609,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3609,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3610,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,N
3610,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
3610,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
3610,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
3610,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3610,6,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3610,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
3611,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
3612,1,Congenital aplasia,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
3612,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3612,3,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
3613,1,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
3613,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
3614,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3614,2,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
3614,3,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
3615,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3616,1,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
3617,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3617,2,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
3617,3,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
3618,1,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
3619,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3619,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
3620,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
3620,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3621,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3621,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3621,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3622,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3623,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3623,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3624,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3625,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3625,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3625,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
3626,1,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
3626,2,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
3627,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3627,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3628,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3628,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3629,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3630,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3631,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3631,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3632,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3633,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3634,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3634,2,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3634,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3634,4,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
3634,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3635,1,B-cell lymphoma recurrent,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
3635,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3635,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3636,1,Antisynthetase syndrome,Muscle infections and inflammations,Muscle disorders,Musc,N
3636,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3636,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3637,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3637,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3637,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3637,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
3637,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3638,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3639,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3640,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3640,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3641,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
3641,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
3642,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3642,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3643,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3643,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3644,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3644,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3645,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3645,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3646,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3646,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3647,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3647,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3648,1,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
3649,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
3650,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3650,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
3651,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3651,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3651,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3651,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3651,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3652,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3652,2,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
3653,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3653,2,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
3654,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3654,2,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
3654,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
3655,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
3656,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
3657,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3657,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3657,3,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
3657,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
3658,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3658,2,Epstein-Barr virus associated lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
3659,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3659,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3660,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3661,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
3662,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3662,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3662,3,Mantle cell lymphoma,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3663,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3663,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3663,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3664,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
3665,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3665,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3666,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3666,2,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
3666,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
3667,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3667,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3668,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
3668,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
3669,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
3669,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
3669,3,Cardiac hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
3669,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3670,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
3670,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
3670,3,Cardiac hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
3670,4,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
3670,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3670,6,Perforation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3671,1,Transitional cell carcinoma,Urinary tract neoplasms malignant NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
3672,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3673,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3674,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3675,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3676,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3676,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3677,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3677,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
3678,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
3679,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3679,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3680,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3680,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3681,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3681,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3682,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3683,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3684,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3685,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
3685,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
3686,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3686,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3687,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3688,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3688,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
3689,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3690,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3690,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3691,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3691,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3692,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3693,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3693,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3694,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
3695,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3696,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3697,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3697,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3697,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3698,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3698,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3699,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3699,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3700,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3701,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3701,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3702,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3703,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3703,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3704,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3704,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3705,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3706,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3706,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3706,3,Blood antidiuretic hormone,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
3706,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3706,5,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
3706,6,Headache,Headaches NEC,Headaches,Nerv,N
3706,7,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
3706,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3706,9,Hypertensive emergency,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
3706,10,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
3706,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3707,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3707,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
3707,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
3708,1,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3708,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3709,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3709,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3710,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
3711,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3711,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
3712,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3713,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3714,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3714,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3715,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
3715,2,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3716,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3717,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3717,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3717,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3718,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
3718,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3719,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
3719,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3720,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3720,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3721,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3722,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3723,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3724,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3724,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3725,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3726,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3726,2,Encephalitis cytomegalovirus,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
3727,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3727,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3727,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3728,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3728,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3728,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
3728,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3728,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3729,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3729,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
3729,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3730,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
3730,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3731,1,Atrial thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3731,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
3731,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3731,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3732,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3733,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3734,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3735,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3735,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3736,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3737,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3738,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3739,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3739,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3740,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3741,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3742,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3742,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3742,3,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3743,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3744,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3744,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3744,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3745,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3746,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3746,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3747,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3747,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3747,3,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
3747,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3748,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3748,2,Oral pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3748,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3748,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3749,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3749,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3749,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3750,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3751,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3752,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3753,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
3754,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3755,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3756,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3756,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3757,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
3758,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3758,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3758,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3759,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3760,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3761,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3761,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3762,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
3762,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3763,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3763,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3764,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3764,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3765,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3765,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3766,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3766,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3766,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3767,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3767,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3768,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3768,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3769,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3769,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3770,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3770,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3771,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3771,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3771,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
3771,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3772,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3773,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3773,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3774,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3775,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3775,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3776,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3777,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3777,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3778,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3778,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
3778,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3778,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3779,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3779,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3780,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3781,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
3781,2,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3782,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3782,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3783,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3783,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3784,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3784,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3785,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3785,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3786,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3787,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3787,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
3787,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3788,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
3788,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3789,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
3789,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
3790,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
3790,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3790,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3791,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3792,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
3792,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3792,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3792,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3792,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
3792,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
3792,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3792,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3792,9,Inflammation,Inflammations,General system disorders NEC,Genrl,N
3792,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3792,11,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3792,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3792,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3793,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3793,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3793,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3794,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3794,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3795,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3796,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3797,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
3797,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3798,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
3798,2,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
3798,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
3799,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3800,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3800,2,Superinfection,Infections NEC,Infections - pathogen unspecified,Infec,N
3801,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3801,2,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
3801,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
3801,4,Deafness,Hearing losses,Hearing disorders,Ear,N
3801,5,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
3801,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3801,7,Normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
3801,8,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
3801,9,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
3801,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
3801,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3801,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3801,13,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
3801,14,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
3802,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
3803,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3803,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3804,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3804,2,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3804,3,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
3804,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,Y
3804,5,Subcutaneous emphysema,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
3805,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3805,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3805,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
3806,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3807,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3807,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3808,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3808,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3809,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3809,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3810,1,B-cell aplasia,Leukopenias NEC,White blood cell disorders,Blood,N
3810,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
3810,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3810,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3811,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3812,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3813,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3814,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3815,1,Deafness,Hearing losses,Hearing disorders,Ear,N
3816,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3816,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3816,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3816,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3816,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3816,6,Headache,Headaches NEC,Headaches,Nerv,N
3816,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3816,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3816,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3816,10,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3817,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3817,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3817,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3817,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3817,5,Headache,Headaches NEC,Headaches,Nerv,N
3817,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3817,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3818,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
3819,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
3820,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3820,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3820,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3820,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3820,5,Headache,Headaches NEC,Headaches,Nerv,N
3820,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3820,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3820,8,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3821,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3821,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3821,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
3821,4,Porphyria,Inborn errors of porphyrin metabolism,Metabolic and nutritional disorders congenital,Cong,N
3821,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3822,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
3823,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
3823,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
3824,1,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3824,2,Post-acute COVID-19 syndrome,Coronavirus infections,Viral infectious disorders,Infec,N
3824,3,Viral vector shedding,Infectious transmissions,Ancillary infectious topics,Infec,N
3825,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3825,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3825,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3825,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3825,5,Headache,Headaches NEC,Headaches,Nerv,N
3825,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3825,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3826,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3826,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3826,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3826,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3826,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
